Skip to main content
eLife logoLink to eLife
. 2021 Jun 9;10:e63417. doi: 10.7554/eLife.63417

Calcium signaling through a transient receptor channel is important for Toxoplasma gondii growth

Karla Marie Márquez-Nogueras 1,2, Miryam Andrea Hortua Triana 1, Nathan M Chasen 1, Ivana Y Kuo 2, Silvia NJ Moreno 1,3,
Editors: Malcolm J McConville4, Dominique Soldati-Favre5
PMCID: PMC8216714  PMID: 34106044

Abstract

Transient receptor potential (TRP) channels participate in calcium ion (Ca2+) influx and intracellular Ca2+ release. TRP channels have not been studied in Toxoplasma gondii or any other apicomplexan parasite. In this work, we characterize TgGT1_310560, a protein predicted to possess a TRP domain (TgTRPPL-2), and determined its role in Ca2+ signaling in T. gondii, the causative agent of toxoplasmosis. TgTRPPL-2 localizes to the plasma membrane and the endoplasmic reticulum (ER) of T. gondii. The ΔTgTRPPL-2 mutant was defective in growth and cytosolic Ca2+ influx from both extracellular and intracellular sources. Heterologous expression of TgTRPPL-2 in HEK-3KO cells allowed its functional characterization. Patching of ER-nuclear membranes demonstrates that TgTRPPL-2 is a non-selective cation channel that conducts Ca2+. Pharmacological blockers of TgTRPPL-2 inhibit Ca2+ influx and parasite growth. This is the first report of an apicomplexan ion channel that conducts Ca2+ and may initiate a Ca2+ signaling cascade that leads to the stimulation of motility, invasion, and egress. TgTRPPL-2 is a potential target for combating toxoplasmosis.

Research organism: Other

Introduction

Ca2+ signaling is universal and forms part of the signaling pathways that activate or modulate a variety of physiological responses like gene transcription, muscle contraction, cell differentiation, and proliferation (Berridge et al., 2003). Ca2+ signals can be generated through the opening of ion channels that allow the downward flow of Ca2+ from either outside the cell or from intracellular stores like the endoplasmic reticulum (ER; Clapham, 2007).

Toxoplasma gondii is an intracellular parasite from the Apicomplexa phylum that causes toxoplasmosis in humans (Blader et al., 2015). Infection with T. gondii may lead to severe complications in immunocompromised patients like encephalitis, myocarditis, and death (Weiss and Dubey, 2009). The T. gondii tachyzoite engages in a lytic cycle directly responsible for the pathogenicity of the infection as it results in lysis of host cells (Black and Boothroyd, 2000). The lytic cycle consists of active invasion of host cells, replication inside a parasitophorous vacuole (PV) and egress to search for a new host cell to invade. Ca2+ signals resulting from Ca2+ entry or from intracellular release trigger a signaling cascade in the parasite that culminates in the stimulation of essential features of its lytic cycle, like motility, invasion, egress, and secretion of proteins essential for attachment to the host cell (Hortua Triana et al., 2018b; Lourido and Moreno, 2015).

Previous work from our lab showed the presence of a Ca2+ entry activity at the plasma membrane of T. gondii tachyzoites that was functional in extracellular (Pace et al., 2014) and intracellular replicating tachyzoites (Vella et al., 2021). The application of voltage-operated Ca2+ channel blockers such as nifedipine inhibited ~80% of Ca2+ influx, and the residual Ca2+ entry activity suggested the potential existence of more than one channel at the plasma membrane of T. gondii (Pace et al., 2014). The molecular nature of these channels has remained elusive. In addition, Ca2+ efflux from the ER into the parasite's cytosol was revealed upon inhibition of the sarcoplasmic-endoplasmic reticulum Ca2+ pump (SERCA) with thapsigargin (Thap) (Moreno and Zhong, 1996Pace et al., 2014). This efflux activity has not been molecularly characterized.

Transient receptor potential (TRP) channels are a large family of ~33 cation-permeable channels grouped into seven subfamilies based on their gene sequence (Nilius and Owsianik, 2011). TRP channels can be activated by a multitude of stimuli and are involved in a wide range of cellular functions (Zhou, 2009). Most TRP channels are permeable to Ca2+, and all of them are permeable to monovalent cations (Zhou, 2009). Some TRP channels can participate in Ca2+ influx as well as Ca2+ release from intracellular stores (Koulen et al., 2002; Venkatachalam and Montell, 2007). Mutations in these molecules are associated with a diverse set of diseases due to their wide distribution in various tissues and their roles in pathological conditions like cancer, making these channels important therapeutic targets (Samanta et al., 2018). The polycystin TRP (TRPP) subfamily of proteins are implicated in autosomal-dominant polycystic kidney disease (ADPKD) (Wang et al., 2019).

Predicted protein sequences with TRP domains have been found in most parasitic protozoa, although in lower numbers and types than in other organisms (Wolstenholme et al., 2011). This could be the result of the evolutionary distance between the species studied or because of loss of specific functions resulting from evolution of the parasitic lifestyle (Wolstenholme et al., 2011). A genome analysis of a number of pathogenic protozoan parasites (Prole and Taylor, 2011) searching for genes with homology to mammalian Ca2+ channels identified two T. gondii hypothetical genes (TgGT1_247370 and TgGT1_310560) with homologous regions to the TRPP family (Boucher and Sandford, 2004). We termed these genes TgTRPPL-1 and TgTRPPL-2. Previous work from our laboratory localized TgTRPPL-1 to the ER with high-resolution tags due to its low level of expression (Hortua Triana et al., 2018a).

In this work, we characterize TgTRPPL-2 in T. gondii, which represents the first TRP cation channel studied in any apicomplexan parasite. Using reverse genetic approaches, we determine the role of TgTRPPL-2 in the lytic cycle of the parasite. We also characterize the electrophysiological features of TgTRPPL-2 and its role in Ca2+ transport and, interestingly, find that pharmacological agents that block the activity of TgTRPPL-2 also inhibit cytosolic Ca2+ influx in the parasite and parasite growth. TgTRPPL-2 emerges as one of the molecular entities involved in initiating Ca2+ signals in T. gondii.

Results

TgTRPPL-2 (TgGT1_310560) localizes to the plasma membrane and the endoplasmic reticulum

Two genes in the T. gondii’s genome annotated as hypothetical proteins possess polycystic kidney disease (PKD) domains, which are characteristic of the Subfamily P (polycystin) of TRP channels. Mammalian TRPP channels contain six transmembrane domains with a large extracellular loop between the first and second transmembrane domain (Montell, 2005). We termed these proteins in T. gondii TgTRPPL-1 (TgGT1_247370) and TgTRPPL-2 (TgGT1_310560). Using BLASTp to compare the amino acid sequences of the human PC2 and TgTRPPL-2 showed low-sequence homology (21.7%), even within the PKD domains. The TgGT1_310560 gene predicts the expression of a protein of 2191 amino acids with an apparent molecular weight of 237 kDa and 14 transmembrane domains. The predicted topology (Omasits et al., 2014) showed a large extracellular loop between the first and second transmembrane domains, which is characteristic of PKD channels (Figure 1A, B). Because our initial analysis showed low-sequence homology, we next analyzed the amino acid sequence using the software HHPred, which searches for homology based on protein sequence and secondary structure (Söding, 2005). Sequence analysis of TgTRPPL-2 showed high homology to human PC2, and the top 10 hits obtained were PC2 homologous from a variety of organisms (Supplementary file 1).

Figure 1. TgTRPPL-2 localizes to the endoplasmic reticulum and periphery of T. gondii.

(A) Schematic representation of the InterPro Domain annotation of TgTRPPL-2 in the GT1 strain. Red line indicates coverage of the sequence by mass spectrometry. (B) Predicted topology for TgTRPPL-2 in GT1 strain. Model was generated with the Protter application (Omasits et al., 2014). The PKD domain is shown in orange. The domain used to generate antibodies is highlighted in green. Predicted Transmembrane Domains (TMDs) are highlighted in purple. The red arrowhead indicates the predicted cleavage site for TgTRPPL2. (C) Schematic representation of C-terminal tagging of TgTRPPL-2 in TatiΔKu80 parasites and western blots of TgTRPPL-2-smHA membranes using αHA (1:1000) showing a major band at approximately 150 kDa (red arrowhead). (D) Immunofluorescence analysis (IFA) of extracellular tachyzoites using αHA antibody and co-localization with αSAG1 (1:1000) and αSERCA (1:1000) showing partial co-localization with both markers. (E) IFAs of extracellular and intracellular (F) tachyzoites respectively with αTgTRPPL-2 (1:100) showing labeling of the protein at the periphery, co-localized with αSAG1 (1:1000) and with αTgSERCA (1:1000). (G) Super-resolution of extracellular IFAs using αTgTRPPL-2 (1:100) co-localized with αSAG1 (1:1000) but not with αGAP45 (1:1000). Scale bars in D-G represent 5 µm.

Figure 1—source data 1. Mass spectrometry results.

Figure 1.

Figure 1—figure supplement 1. Validation of C-terminal tagging of TgTRPPL-2-smHA.

Figure 1—figure supplement 1.

(A) Amplification of ~2 kB in the TgTRPPL-2-smHA cell line validating the correct integration of TgTRPPL-2-smHA. (B) Western blot of three biological replicates of immunoprecipitated TgTRPPL-2-smHA using αHA antibody (1:1000) shows a band of ~150 kDa (highlighted by red boxes and arrow). No band is present in the control cell line. (C) Immunofluorescence analysis (IFA) of intracellular tachyzoites with αHA (1:100), αSAG1 (1:1000), and αGAP45 (1:1000) . (D) IFAs of intracellular and extracellular tachyzoites with αHA (1:100) show that TgTRPPL-2 did not co-localize with either αGAP45 (1:1000) or αGra1 (1:500). (E) IFAs of extracellular tachyzoites preincubated with α-toxin showing co-localization of TgTRPPL-2 with αSag1 (1:1000) but not with αGap45. (F) Quantification of Pearson’s coefficient of the co-localization of TgTRPPL2 with SAG1 or GAP45.
Figure 1—figure supplement 1—source data 1. Summary statistics of Pearson's coefficient analysis.

To investigate the localization of TgTRPPL-2, we introduced the high-affinity tag smHA (Hortua Triana et al., 2018a) at the 3′ terminus of the TgTRPPL-2 locus and isolated TgTRPPL-2-smHA cell clones. Carboxy-terminus tagging was done in the parental line RHTatiΔku80 (TatiΔku80), which favors homologous recombination (Sheiner et al., 2011). Correct incorporation of the tag in the TgTRPPL-2-smHA line was validated by PCR (Figure 1—figure supplement 1A) and western blot analysis using anti-HA antibodies (Figure 1C). A band of approximately ~150 kDa was observed in lysates of TgTRPPL-2-smHA tachyzoites, which is nearly 87 kDa smaller than the predicted size of 237 kDa without taking into account the smHA tag (~39 kDa).

To further demonstrate that the protein band observed in the western blot analysis corresponded to the tagged TgTRPPL-2 gene, we performed immunoprecipitations with anti-HA of lysates from the TgTRPPL-2-smHA cells. The immunoprecipitated samples were separated in a PAGE gel. The ~150 kDa band was excised and analyzed by mass spectrometry Figure 1—figure supplement 1B red boxes (Supplementary file 2). The peptides recovered are shown matching the TgGT1_310560-predicted protein sequence, which cover ~700 amino acids of the C-terminus domain (Figure 1A, red bars). This result indicated that the TgGT1_310560 is likely cleaved, a characteristic common with other TRP channels (Merrick et al., 2014). The predicted cleavage site is shown in Figure 1B.

We next investigated the cellular localization of TgTRPPL-2. Immunofluorescence analysis (IFA) of extracellular and intracellular parasites showed that TgTRPPL-2-smHA localizes to peripheral vesicles close to the plasma membrane and to the ER (Figure 1D). Some co-localization with the plasma membrane surface antigen (SAG1) and the sarcco-endoplasmic reticulum Ca2+ ATPase (TgSERCA) (ER marker) was observed in IFAs (Figure 1D) while the vesicular pattern did now show co-localization with dense granules (Figure 1—figure supplement 1D). However, considering the low level of expression of TgTRPPL-2, it was difficult to draw definitive conclusions about its localization.

We next generated polyclonal antibodies against a fragment peptide of TgTRPPL-2, indicated in Figure 1A (highlighted in green). The peptide was expressed in bacteria, purified, and used for immunization of mice. Mouse serum was isolated and affinity purified prior to its use. The localization at the periphery of extracellular tachyzoites was further confirmed by co-localization with αSAG1 (Figure 1E–G). In addition, extracellular and intracellular tachyzoites showed staining that co-localized with TgSERCA (Figure 1E, F), supporting ER localization. IFAs of intracellular tachyzoites showed that TgTRPPL-2 co-localized with αSAG1 and αSERCA (Figure 1F). Super-resolution images with the anti-TgTRPPL-2 antibody showed localization to the periphery in close contact with the SAG1 marker (Figure 1—figure supplement 1E). TgTRPPL-2 did not appear to overlap with GAP45 (Figure 1—figure supplement 1E), which is supported by Pearson's coefficient quantification.

In summary, TgTRPPL-2 is expressed in T. gondii tachyzoites, is likely post-translationally cleaved, and localizes to the ER and the periphery.

TgTRPPL-2 is important for growth, invasion, and egress of T. gondii

With the aim of investigating the physiological role of TgTRPPL-2 in T. gondii, we generated the ΔTgTRPPL-2 mutant using the CRISPR-Cas9 approach (Shen et al., 2017) to disrupt the transcription of TgTRPPL-2 by inserting a dihydrofolate reductase-thymidylate synthase (DHFR) cassette in the TgTRPPL-2 genomic locus (Figure 2A). Genetic controls for the insertion were done by PCR (Figure 2—figure supplement 1A) and qPCR, which showed a significant decrease in the levels of TgTRPPL-2 transcripts (Figure 2B).

Figure 2. The role of TgTRPPL-2 in T. gondii growth.

(A) Schematic representation of the generation of ΔTgTRPPL-2 in the T. gondii RH strain. (B) qPCR of total RNA from ΔTgTRPPL-2 (Δ), ΔTgTRPPL-2-trppl2 (C), and parental strains (P) using primers upstream and downstream of the insertion site of the dihydrofolate reductase-thymidylate synthase cassette. (C) Immunofluorescence analysis of extracellular parasites showing plasma membrane labeling with αTgTRPPL-2 (1:1000) and co-localization with αSERCA (1:1000). (D) Plaque assays of parental (P), ΔTgTRPPL-2 (Δ), and ΔTgTRPPL-2-trppl2 (C) parasites. Quantification of plaque sizes from three independent biological experiments using Student’s t-test. Values are means ± SEM. ****p<0.0001. (E) Red green assays of parental, and ΔTgTRPPL-2 cells quantifying invaded and attached intracellular parasites. Assays were done at two concentrations of extracellular Ca2+: 0.5 and 1.8 mM. Values are means ± SEM. **p<0.001, ****p<0.0001. (F) Time to egress stimulated by saponin/Ca2+ at 1.8 mM extracellular Ca2+ of both parental and the ΔTgTRPPL-2 mutant. (G) Statistical analysis of average egress time stimulated by saponin or Zaprinast in the presence or absence of extracellular Ca2+. Analysis was performed from three independent biological replicates using Student’s t-test. Values are means ± SEM, **p<0.003, ****p<0.0001. Black bars represent parental strain, blue bars represent ΔTgTRPPL-2. Scale bars for C represent 5 µm.

Figure 2—source data 1. Statistical analysis of data.

Figure 2.

Figure 2—figure supplement 1. Validation of the anti-TgTRPPL-2 antibody.

Figure 2—figure supplement 1.

(A) Genomic validation of the insertion of the dihydrofolate reductase-thymidylate synthase cassette in the ΔTgTRPPL-2 locus. Primers used are shown in Figure 2A. (B) Western blot analysis of total lysates from different cells lines were run in an SDS-PAGE and developed with αTgTRPPL2 (1:1000) and αTubulin (1:10,000) (1: ΔKu80Tati; 2: TgTRPPL2-smHA; 3: RH; 4: ΔTgTRPPL-2). Note that all cell lines show a band at ~115–120 kDa and lane 2 (tagged line) shows two bands one at ~115–120 kDa and an additional band of ~150 kDa due to the presence of the smHA tag, which adds approximately 39 kDa to the protein. The sum of these two bands (120 + 150 kDa) represents the size predicted for TgTRPPL2 tagged with the smHA tag in ToxoDB. (C) Western blots of lysates from parental, ΔTgTRPPL-2 (Δ) and ΔTgTRPPL-2-trppl2 (C) cells were run in an SDS-PAGE cell and developed with the anti-TgTRPPL-2 antibody at 1:1000. αTubulin (1:10,000) was used as loading control. (D) Immunofluorescence analysis of extracellular tachyzoites with αTgTRPPL-2 (1:1000) co-localized with αSERCA (1:1000) in ΔTgTRPPL-2 and ΔTgTRPPL-2-trppl2. Scale bars represent 5 μm. Images were taken with equivalent time and laser power.

We next complemented the ΔTgTRPPL-2 mutant with Cosmid PSBLZ13 (Vinayak et al., 2014) that contains the whole genomic locus of the TgTRPPL-2 gene and generated the cell line ΔTgTRPPL-2-trppl2. Controls for the expression of TgTRPPL-2 were done by qPCR (Figure 2B) and IFAs, which further confirmed the identity of the tagged gene, as it was not expressed in the ΔTgTRPPL-2 mutants and was present in the complemented line ΔTgTRPPL-2-trppl2 (Figure 2C). Further validation of the absence of expression of TgTRPPL-2 and its complementation is shown in Figure 2—figure supplement 1 with western blots analyses with mouse α-TgTRPPL-2 antibody and additional IFA images of the ΔTgTRPPL-2 and ΔTgTRPPL-2-trppl2 (Figure 2—figure supplement 1B, D). The western blots in Figure 2—figure supplement 1B, C showed a band at ~115 kDa in lysates of TatiΔku80, TgTRPPL-2-smHA and RH (wild type strain), which was absent in the ΔTgTRRPL-2 mutant. This band most likely represented the endogenously cleaved TgTRPPL-2. In the TgTRPPL2-smHA mutant lysate there was an additional band of ~150 kDa from the smHA tag, which added approximately 39 kDa to the protein, because of the smHA tag. The sum of both bands (120 + 150 kDa) represents the size predicted for TgTRPPL-2 in ToxoDB plus the smHA tag.

We next evaluated if the expression of TgTRPPL-2 would impact T. gondii growth by plaque assays, in which the parasite engages in repetitive cycles of invasion, replication, and egress causing host cell lysis and formation of plaques is observed as white spots by staining with crystal violet. The ΔTgTRPPL-2 mutant formed smaller plaques compared to its parental counterpart, indicating a growth defect (Figure 2D). This growth defect was partially restored in the complemented cell line (Figure 2D). We reasoned that the overexpression of TgTRPPL-2 in the ΔTgTRPPL-2-trppl2 mutant likely affected parasite fitness masking the rescue effect.

To determine which step of the lytic cycle was affected, we performed invasion and egress assays. For invasion, we used the red green assay (Kafsack et al., 2004) under two extracellular Ca2+ (1.8 and 0.5 mM) conditions. Quantification of invasion in the presence of 1.8 mM Ca2+ showed a lower invasion rate for the ΔTgTRPPL-2 (Figure 2E). Reducing the extracellular concentration of Ca2+ to 0.5 mM resulted in a reduced rate of invasion in the parental cell line, which was similar to the invasion rate of the ΔTgTRPPL-2 mutants. This result suggested that TgTRPPL-2 is likely functional at higher concentrations of extracellular Ca2+.

Egress of intracellular tachyzoites can be triggered by permeabilizing infected host cells with saponin in the presence of a buffer containing 1.8 mM Ca2+. Under these conditions, egress of the ΔTgTRPPL-2 mutant was slower than egress of the parental strain (Figure 2F). Additionally, when egress was stimulated by the phosphodiesterase inhibitor Zaprinast, which increases cytosolic Ca2+ by permitting increase of the cyclic nucleotide cGMP (Brown et al., 2016; Sidik et al., 2016), it also resulted in the ΔTgTRPPL-2 mutant taking longer to egress (Figure 2G). This delayed egress was observed with and without extracellular Ca2+. For both assays tested, the ΔTgTRPPL-2 mutant took twice the time to egress compared to the parental line.

In summary, disruption of the TgTRPPL-2 locus negatively impacted two important steps of the T. gondii lytic cycle, invasion and egress, which impaired parasite growth.

TgTRPPL-2 is important for cytosolic Ca2+ influx

We previously showed that T. gondii extracellular tachyzoites allow influx of Ca2+ when exposed to 1.8 mM extracellular Ca2+ (Pace et al., 2014). To determine the role of TgTRPPL-2 in this pathway, we loaded extracellular ΔTgTRPPL-2 parasites with Fura-2-AM to study intracellular Ca2+ changes after exposing them to 1.8 mM extracellular Ca2+ (Figure 3A). The resting cytosolic Ca2+ concentration of the ΔTgTRPPL-2 mutant was around 75 nM, which is similar to the resting concentration of parental cells (~70–100 nM). Adding 1.8 mM Ca2+ to the extracellular buffer caused an increase in cytosolic Ca2+ in both the parental strain and the ΔTgTRPPL-2 mutant (Figure 3B). However, Ca2+ influx of the ΔTgTRPPL-2 mutant was decreased by approximately 50% (Figure 3C). The ΔTgTRPPL-2-trppl2 mutant, however, regained the Ca2+ influx activity and showed higher Ca2+ influx than parental cells, consistent with the higher expression of TgTRPPL-2 shown by qPCR (Figure 2B). The reduction of Ca2+ influx was further confirmed when adding 1 mM extracellular Ca2+ to the ΔTgTRPPL-2 mutant (Figure 3—figure supplement 1A).

Figure 3. The role of TgTRPPL-2 in PM Ca2+ influx.

(A) Scheme showing the mechanism of Ca2+ influx and how cytosolic Ca2+ may activate the PM channel (Ca2+-activated calcium entry). NSC: nifedipine-sensitive channel; PKG: protein kinase G; PDE: phosphodiesterase; Thap: thapsigargin; Zap: Zaprinast.(B) Cytosolic Ca2+ measurements of Fura-2 loaded tachyzoites of the parental (RH), ΔTgTRPPL-2 and ΔTgTRPPL-2-trppl2 lines. The buffer contains 100 μM ethylene glycol-bis(β-aminoethyl ether)-N,N,N′,N′-tetraacetic acid (EGTA) to chelate contaminating Ca2+ and at 300 s, 1.8 mM Ca2+ were added to the suspension. The pink box indicates the area used for the quantification presented in (C). (C) Quantification and statistical analysis of the change in cytosolic Ca2+ during the first 20 s after addition of extracellular Ca2+. ***p<0.0002. (D) Constitutive Ca2+ influx into the cytosol of parasites suspended in a buffer with 1.8 mM Ca2+. (E) Quantification and statistical analysis of the slopes from (D). ****p<0.0001. (F) Cytosolic Ca2+ increase after adding Thap (1 µM) followed by Ca2+ influx after the addition of 1.8 mM extracellular Ca2+ at 400 s. The pink boxes indicate the area used for the quantification presented in (G) and (H). (G) Quantification and statistical analysis of the change in cytosolic Ca2+(Δ[Ca2+]cyt) at 50 s after the addition of Thap. (H) Quantification of the Δ[Ca2+]cyt 20 s after the addition of 1.8 mM of Ca2+. ***p<0.0008, ****p<0.0001. (I) Cytosolic Ca2+ increase stimulated by Zaprinast (100 µM) in the presence of 1.8 mM extracellular Ca2+. (J) Quantification and statistical analysis of the Δ[Ca2+]cyt during the first 15 s after adding Zaprinast (100 µM) (pink box, in I). **p<0.001, ****p<0.0001. (K) Quantification and statistical analysis of the Δ[Ca2+]cyt during the 20 s after adding Ca2+ without additions (ND) or after adding Thap or Zap. *p<0.02, **p<0.005, ***p<0.0008. Statistical analysis for all experiments was done from a minimum of three independent trials using Student’s t-test.

Figure 3—source data 1. Quantification and statistics of calcium measurements.

Figure 3.

Figure 3—figure supplement 1. TgTRPPL-2 regulates Ca2+in T. gondii.

Figure 3—figure supplement 1.

(A) Cytosolic Ca2+ measurements of Fura-2-loaded tachyzoites of the parental and ΔTgTRPPL-2 mutant after addition of 1 mM extracellular Ca2+ at 300 s. (B) Cytosolic Ca2+ measurement after the addition of Zaprinast (100 µM) at 100 s and Ca2+ influx stimulated by the addition of 1.8 mM extracellular Ca2+ at 400 s. (C) Change in cytosolic Ca2+ 15 s after the addition of Zaprinast (labeled Zaprinast) and 20 s after the addition of 1.8 mM of extracellular Ca2+ (labeled Ca2+after Zaprinast). Values are means ± SEM, n = 3, **p<0.007, ****p<0.0001. Measurements of the complemented strain are not shown as the concentration of calcium goes outside the Fura 2 range.
Figure 3—figure supplement 1—source data 1. Quantification and statistics of calcium measurements.

When T. gondii extracellular tachyzoites were suspended in a high Ca2+ buffer, a slow constitutive cytosolic influx of Ca2+ was observed, which we attribute to leakage through a PM channel (Figure 3D, parental black tracing). Interestingly, this leakage activity was significantly reduced in the ΔTgTRPPL-2 mutant (Figure 3D, E, blue tracing and bar), suggesting a role for TgTRPPL-2 in constitutive cytosolic Ca2+ influx at the PM. Additional evidence is provided by the enhanced Ca2+ leakage observed with the ΔTgTRPPL-2-trppl2 (Figure 3D, E, purple trace and bar). The high level of Ca2+ influx observed with the ΔTgTRPPL-2-trppl2 mutant may affect parasite fitness and would explain the partial growth recovery observed with this mutant.

Ca2+ channels may also be modulated by Ca2+ itself (Petri et al., 2010). We previously showed that a cytosolic [Ca2+] increase may activate Ca2+ influx at the PM (Ca2+-activated-Ca2+ entry) (Pace et al., 2014). We next investigated if TgTRPPL-2 expressed at the PM played a part in the Ca2+-activated-Ca2+ entry (CACE) activity. We added Thap to tachyzoites in suspension (Figure 3F), which resulted in a cytosolic Ca2+ increase due to inhibition of the SERCA-Ca2+-ATPase (SERCA) and in uncompensated Ca2+ efflux into the cytosol. This elevated cytosolic Ca2+ stimulated further Ca2+ influx at the PM, which was observed as an increased rate of extracellular Ca2+ influx (Figure 3F, black trace). The rate of Ca2+ increase (Δ[Ca2+]cyt) was measured as the change in the [Ca2+]cyt following the addition of Thap (Figure 3G) and following the addition of Ca2+ (Figure 3H). Note that the Δ[Ca2+]cyt shown in Figure 3H, black column, was almost 2.5 times higher than the Δ[Ca2+]cyt observed without previous addition of Thap (Figure 3C, black column). This CACE activity was absent in the ΔTgTRPPL-2 mutant (Figure 3F, blue trace) but was restored in the ΔTgTRPPL-2-trppl2-complemented strain (Figure 3F, purple trace). Quantifications of the rate of Ca2+ increase after adding Ca2+ and statistical analyses are shown in Figure 3H. Note that the ΔTgTRPPL-2 mutant showed a reduced response to the addition of Thap and also to the addition of Ca2+. Comparing the response to the addition of extracellular Ca2+ shown in Figure 3H, blue column, the Δ[Ca2+]cyt is similar to the one measured directly without previous addition of Thap (compare with the blue column in Figure 3C). This result points to a complete absence of the modulatory effect of cytosolic Ca2+ on the PM Ca2+ influx in the ΔTgTRPPL-2 mutant, which was restored in the ΔTgTRPPL-2-trppl2 mutant.

We next tested the effects of Zaprinast. We previously showed that cytosolic Ca2+ increase was almost 2.5 times higher in the presence of extracellular Ca2+ compared with the absence of extracellular Ca2+ (Sidik et al., 2016). We attributed this increase to stimulation of the PM Ca2+ channel by cytosolic Ca2+ (CACE). When testing CACE with the ΔTgTRPPL-2 mutants, we observed that the increased response was absent (Figure 3I–K). Even the release of Ca2+ from intracellular stores by Zaprinast in the presence of low extracellular Ca2+ (~50 nM) was significantly decreased in the ΔTgTRPPL-2 mutant (Figure 3—figure supplement 1B, C). The modulatory action of elevated cytosolic Ca2+ in Ca2 entry is shown in Figure 3K, which compares the Δ[Ca2+]cyt rate following the addition of thapsigargin (TG) or Zaprinast (ZA), which is absent in the ΔTgTRPPL-2 mutant (Figure 3I–K).

Taken together, these results support a role for TgTRPPL-2 in Ca2+ influx at the PM. In addition, TgTRPPL-2 is modulated by cytosolic Ca2+ and is responsible for constitutive PM Ca2+ influx.

TgTRPPL-2 is a cation-conducting channel

With the aim of establishing whether TgTRPPL-2 functions as a channel and whether it is able to conduct Ca2+, we cloned the cDNA of the TgTRPPL-2 gene into a mammalian expression vector (pCDNA3.1) for expression in human embryonic kidney 293 cells (HEK-3KO) (Alzayady et al., 2016). These HEK cell line is genetically modified and the three isoforms of the inositol 1,4,5-trisphosphate receptor (IP3R) are deleted to reduce background Ca2+ currents (Alzayady et al., 2016). TgTRPPL-2 was mostly expressed at the ER of HEK cells as assessed by co-localization with a red fluorescent protein (mCherry) targeted to the ER and compared with the human homolog polycystin 2 (PC2) (Figure 4A). Because of this, we isolated nuclei (Figure 4B) for patch clamp experiments of the nuclear ER and further characterization of the permeability properties of TgTRPPL-2 using a modified outside-out single-channel patch clamp configuration called cytosolic-side out (Mak et al., 2013bFigure 4B, C).

Figure 4. Characterization of TgTRPPL-2 expressed in HEK-3KO cells.

Figure 4.

(A) Images of HEK-3KO cells expressing an endoplasmic reticulum (ER)-marker, polycystin 2 (PC2), or TgTRPPL-2 with the genetic calcium indicator gCaMPer. (B) Schematic representation of nuclear-patch clamp in the outside (cytosolic-side) out configuration. Ionic composition and concentration for bath and pipette solutions are shown. (C) Patched nuclear-extract expressing ER-marker, PC2, and TgTRPPL-2 with the genetic calcium indicator gCaMPer. (D) Representative tracing from control, TgTRPPL-2 or PC2-expressing cells showing the currents recorded in the presence of 1.8 mM luminal Ca2+ in a symmetrical potassium chloride solution. Tracings represent approximately 2 s. (E) Current-voltage relationship comparing single-channel current amplitude of control, PC2, and TgTRPPL-2-expressing cells from (D). Inset: calculated slope conductance for control, TgTRPPL-2, and PC2. (F) Current-voltage relationship comparing single-channel current amplitude of TgTRPPL-2-expressing cells at 1.8 and 10 mM [Ca2+] inside the pipette. Inset: calculated slope conductance for the conditions analyzed. (G) Representative traces of currents recorded from TgTRPPL-2-expressing cells using different concentration of [Ca2+] in the bath solution (Solution A vs. Solution C) (Supplementary file 4). Tracings represent approximately 2 s. (H) Current-voltage relationship comparing single-channel current amplitude of TgTRPPL-2-expressing cells at 0.1 and 10 μM [Ca2+] in the bath solution. Inset: calculated slope conductance for the different [Ca2+]. (I) Open probability of control and TgTRPPL-2-expressing cells in the presence of different [Ca2+] in the bath solution in comparison to the control. *p<0.01, **p<0.001. Scale bars in A and C represent 10 µm.

Figure 4—source data 1. Open probability measurements and statistics.

In the presence of 1.8 mM Ca2+ inside the patch pipette and 100 nM Ca2+ in the bath solution (see scheme of Figure 4B), the membranes isolated from control cells, held at –80 mV, showed very little activity and the current remained at less than 1.5 pA (Figure 4D, control trace). Some channel activity was observed after artificially depolarizing membranes (–80 to +20 mV) presumably due to opening of potassium channels. In comparison, when analyzing membranes isolated from cells expressing TgTRPPL-2 a significant increase in the open probability and current size was observed (Figure 4D, TgTRPPL-2 blue trace). The current-voltage relationship was linear and significantly different from the one from control cells (Figure 4E, blue vs. black line).

We compared the activity of TgTRPPL-2 with the human TRPP channel PC2 in parallel experiments since PC2 has been well characterized in the literature. Activity of PC2-expressing cells displayed a voltage-dependent behavior as the current-voltage relationship was not linear, with a conductance of ~73 pS (Figure 4D, E, red trace). Previous work has demonstrated that PC2 can be voltage dependent (Kleene and Kleene, 2017). Depending on the experimental conditions, the conductance for PC2 varied between different reports (Kleene and Kleene, 2017). However, comparing our experimental approach to previous work with similar experimental solutions, our calculated slope conductance for PC2 in a high Ca2+ solution was comparable (~73 pS vs. ~97 pS). In contrast to human PC2, TgTRPPL-2 does not appear to be voltage dependent, and the conductance (55 pS) of the channel was similar to the human homologue.

Polycystin TRP channels have been shown to be activated by Ca2+ due to the presence of an EF-hand motif at the C-terminus (Celić et al., 2008; Petri et al., 2010). To determine whether Ca2+ can modulate the activity of TgTRPPL-2, we varied the [Ca2+] inside the pipette (i.e., the luminal side). When the Ca2+ concentration was increased from 1.8 mM to 10 mM Ca2+, there was a significant inhibition of TgTRPPL-2 channel activity. With high pipette Ca2+ concentration, the channel displayed voltage-dependent inhibition over the −80 to −20 mV range and conductance was significantly decreased (Figure 4F). The conductance decreased to ~21 pS when Ca2+ was increased to 10 mM.

Although no evidence for a conserved EF-hand motif was found in TgTRPPL-2, we checked for the potential modulation by cytosolic Ca2+. Increasing the concentration of Ca2+ in the bath solution from 100 nM to 10 µM (which would simulate changes in cytosolic Ca2+) enhanced channel activity from membranes expressing TgTRPPL-2 (Figure 4G, H, blue vs. gold line). Interestingly, increasing the [Ca2+] only increased the open probability at −80 mV (Figure 4I). However, increase of the [Ca2+] of the bath solution increased the conductance of the channel almost 2.5×, suggesting modulation of the channel by Ca2+ itself. These data indicate that TgTRPPL-2 was able to conduct Ca2+ currents and was modulated by cytosolic Ca2+.

To distinguish whether TgTRPPL-2 is able to conduct cation currents and to determine if the activity measured could be the result of permeation of potassium, we replaced potassium with the non-permeable ion cesium (Almog and Korngreen, 2009; Wu et al., 1999). In the presence of 1.8 mM Ca2+ inside the pipette, in a cesium chloride solution, membranes from TgTRPPL-2 and PC2-expressing cells had a significantly higher activity than control cells (Figure 5A). The current-voltage relationship was linear through different applied voltages and significantly different from that of control cells in potassium or cesium chloride solution (Figure 5B). Although channel conductance was slightly higher in potassium chloride, it was not significantly different than the calculated conductance and open probability obtained in cesium chloride (Figure 5B, C). However, when applying voltages higher than −40 mVs, the channel was open for longer times in the presence of cesium chloride vs. potassium chloride with calcium (Figure 5D, green vs. blue line). These results indicated that TgTRPPL-2 permeates Ca2+, however, potassium may modify the current properties.

Figure 5. TgTRPPL-2 permeates Ca2+.

(A) Representative traces of currents recorded at −80 mV in the presence of 1.8 mM Ca2+ inside the pipette (Solution D, Supplementary file 4) of nuclear extracts from control, TgTRPPL-2-, or polycystin 2 (PC2)-expressing cells. Traces are a representation of 2 s. (B) Current-voltage relationship comparing single-channel current amplitude of TgTRPPL-2 cells in 1.8 mM in KCl (blue) or CsCl (green) buffer. Inset: slope conductance of TgTRPPL-2 in the different conditions analyzed. (C) Calculated open probability of TgTRPPL-2-expressing cells in the presence of 1.8 mM Ca2+ in a KCl (blue) or CsCl (green) buffer. (D) Average time of channel openings (dwell time) of TgTRPPL-2-expressing cells in the presence of 1.8 mM Ca2+ in a KCl (blue) or CsCl (green). *p<0.04. Values are means ± SEM.

Figure 5—source data 1. Channel amplitude measurements, open probability, and statistics.

Figure 5.

Figure 5—figure supplement 1. Measurement of endoplasmic reticulum (ER) calcium of HEK-3KO cells expressing TgTRPPL-2.

Figure 5—figure supplement 1.

(A) Fluorescence of ER calcium in ER-RFP-HEK (Control) vs. TgTRPPL-2-HEK (TgTRPPL-2) in a high calcium-potassium solution of patched nuclear membranes while the membrane is depolarized. (B) Quantification of fluorescence of patched cells while the membrane is depolarized from −80 to +40 mV in a high calcium-potassium solution. (C) Quantification of the slope of fluorescence in (B) comparing TgTRPPL-2-HEK-3KO cells versus control cells. Slope of the fluorescence was quantified based on the five technical replicates of the artificial membrane depolarization in each cell analyzed. Asterisk indicate p-value for significant difference. Values represent the mean of the slope shown in (B). *p<0.01. (D) Quantification of fluorescence of patched cells while the membrane is depolarized from −80 to +40 mV in a high calcium-cesium solution. (E) Quantification of the slope of fluorescence in (D) comparing TgTRPPL-2-HEK-3KO cells versus control cells. The slope was quantified for the five technical replicates of patched membranes. Asterisk indicates p-value for significant difference. Values represent the mean of the slope shown in (D). *p<0.03. (F) Comparison of the fluorescence of patched nuclear extract of TgTRPPL-2-HEK cells while the membrane was artificially depolarized. (G) Quantification of the slope of fluorescence of patched TgTRPPL-2-HEK-3KO nuclear extracts in different experimental conditions. Slope of the fluorescence was quantified based on the five technical replicates of the artificial membrane depolarization in each cell analyzed.
Figure 5—figure supplement 1—source data 1. Calcium fluorescence measurements and statistics.

We further demonstrated that TgTRPPL-2 was able to conduct Ca2+ by recording Ca2+ changes of TgTRPPL-2-HEK-3KO or mCherry-ER-HEK-3KO cells co-transfected with a genetic Ca2+ indicator, which enabled measurement of ER luminal Ca2+ changes and whole-ER current activity (by breaking into the ER, but not pulling the membrane away) simultaneously. Luminal Ca2+ changes were followed through one cycle of membrane depolarization from −80 mV to 40 mV (Figure 5—figure supplement 1A). The fluorescence of the Ca2+ indicator decreased in the TgTRPPL-2-expressing cells with time as voltage was applied. In both potassium as well as cesium chloride solutions with 1.8 mM Ca2+ in the pipette, we observed that the fluorescence decrease was significantly larger when the HEK-3KO cells expressed TgTRPPL-2 (Figure 5—figure supplement 1B, C vs. D, E). The slope for the fluorescence decrease appeared higher in the cesium chloride solution than in the potassium solution, although was quite variable (Figure 5—figure supplement 1F, G). In summary, the observed decrease in the fluorescence of the Ca2+ indicator supported the Ca2+ permeation activity of TgTRPPL-2, which agrees with the single-channel conductance measurements.

TgTRPPL-2 can be inhibited by TRP channel inhibitors and is functional at the membrane of the ER

Taking into account that TgTRPPL-2 is a cation-permeable channel and partially localizes to the periphery (Figure 6A), we next investigated if the residual Ca2+ influx activity observed with the ΔTgTRPPL-2 mutant was sensitive to anthranilic acid (ACA), a wide spectrum TRP channel inhibitor (Harteneck et al., 2007). ACA inhibited Ca2+ influx by 40–50% of the parental cell line (Figure 6B, black vs. red traces). However, preincubation of the ΔTgTRPPL-2 mutant with ACA did not further reduce Ca2+ influx (Figure 6B, dark blue vs. light blue and 6C, blue points). We previously reported that Ca2+ influx in T. gondii was inhibited by L-type voltage-gated Ca2+ channel blockers like nifedipine (Pace et al., 2014). Preincubation with nifedipine inhibited Ca2+ influx of the parental cell line by almost 80% (Figure 6D, black vs. green bar in P). The rate of Ca2+ influx, defined as the ΔCa2+ immediately following the addition of Ca2+, of the ΔTgTRPPL-2 mutant was inhibited by nifedipine by almost 100% (Figure 6D, black vs. green bar in Δ). Rates of ΔCa2+ after adding extracellular Ca2+ and its inhibition by ACA and nifedipine for parental (P), ΔTgTRPPL-2 (Δ), and ΔTgTRPPL-2-trppl2 (C) mutants are shown in Figure 6D. The ΔCa2+ was highest for the complemented mutant as TgTRPPL-2 was overexpressed but the % of inhibition by ACA was still around 50% (Figure 6D, black vs. purple bar in C). These results point to TgTRPPL-2 functioning as a Ca2+ conducting channel that is important for Ca2+ influx from the extracellular milieu and is sensitive to TRP channel inhibitors.

Figure 6. Regulation of TgTRPPL-2 by Ca2+and inhibition by transient receptor potential inhibitors.

Figure 6.

(A) Scheme showing TgTRPPL-2 at the PM and endoplasmic reticulum. (B) Cytosolic Ca2+ measurements of Fura-2-loaded tachyzoites preincubated with 1 µM anthranilic acid (ACA). 1.8 mM Ca2+ was added where indicated. The purple box indicates the area used for the quantification presented in (D). (C) Percentage inhibition of Ca2+ influx in the presence of 1 µM of ACA: P: parental, Δ: ΔTgTRPPL-2 and C: ΔTgTRPPL-2-trppl2. (D) Change in cytosolic Ca2+ during the first 20 s after addition of Ca2+ in the presence of 10 µM of nifedipine or 1 µM ACA. P: parental, Δ: ΔTgTRPPL-2 and C: ΔTgTRPPL-2-trppl2. *p<0.01, **p<0.003, ****p<0.0001. (E) Cytosolic Ca2+ increase after adding Thap (1 µM) to a suspension of wild-type tachyzoites (RH). The red line shows a similar experiment, but the cells were preincubated with 1 µM ACA for 3 min. The pink and orange boxes show the areas used for the quantifications presented in (F) and (H). (F) Quantification and statistical analysis of the slope 50 s after the addition of Thap in the presence or absence of ACA in parental (P) and the ΔTgTRPPL-2 mutant (Δ). *p<0.01, ***p<0.0003. (G) Stimulation of Ca2+ influx 50 s after addition of Thap in the presence or absence of 1 µM ACA. The green box shows the area used for the quantifications presented in (H). (H) Quantification of change of cytosolic Ca2+ 20 s after the addition of 1.8 mM Ca2+ following the addition of Thap under different conditions. ****p<0.00001. The statistical analysis for all experiments was done from at least three independent trials using Student’s t-test. Values are means ± SEM.

Figure 6—source data 1. Quantification and statistics of calcium measurements.

The localization of TgTRPPL-2 at the ER of tachyzoites (Figure 1D) indicated its potential function in cytosolic Ca2+ efflux observed after inhibiting TgSERCA with Thap (Moreno and Zhong, 1996). ER efflux activity observed after addition of Thap was significantly decreased by preincubation of Fura-2-loaded wild-type tachyzoites with ACA (Figure 6E, black vs. red traces). Interestingly, ACA inhibited the rate of ER Ca2+ efflux, which was comparable to the reduced efflux rate triggered by Thap of the ΔTgTRPPL-2 mutant (Figure 6F, compare red and blue bar).

We next investigated whether ACA inhibited the previously described CACE mechanism (Pace et al., 2014). We first tested the parental strain by preincubating parasites with ACA, adding Thap at 100 s followed by the addition of extracellular Ca2+ as indicated (Figure 6E–G). Example traces demonstrating Ca2+ entry at the PM by elevated cytosolic Ca2+ are shown at two different times after the addition of Thap, 50 s (Figure 6G) and 300 s (Figure 6E). The analysis of the rates is shown in Figure 6H, and the comparison of the Δ[Ca2+]/s of Ca2+ entry without previous addition of Thap (Figure 6H, black bar) with the rate at 50 s and at 300 s after Thap (Figure 6H, green and maroon). This stimulation by cytosolic Ca2+ was abolished by ACA (Figure 6E, black vs. red trace and 6H, gold and red bars). Ca2+ entry following cytosolic Ca2+ increase by Thap addition was also reduced to the basal rate in the ΔTgTRPPL-2 mutant (Figure 6H, blue bar). The modulation of the Ca2+ entry mechanism by cytosolic Ca2+ was lost in the ΔTgTRPPL-2 mutant (Figure 6H, black vs. blue bars). These data suggest that ACA inhibited both efflux of Ca2+ from the ER as well as Ca2+-induced Ca2+ entry. This led us to propose that TgTRPPL-2, in addition to mediating Ca2+ entry at the plasma membrane, may also mediate Ca2+ efflux/leakage from the ER, a pathway sensitive to the TRP channel inhibitor ACA.

To further validate the specificity of ACA for the inhibition of TgTRPPL-2, we tested the ability of this inhibitor and a second broad-spectrum TRP channel inhibitor, benzamil, to inhibit single-channel current activity. The channel activity of TgTRPPL-2 was significantly decreased by both ACA and benzamil (Figure 7A). ACA diminished the amplitude of the current, reduced the open probability, and the time that the channel remained open (dwell time) (Figure 7B). Of the current that remained in the presence of ACA, the conductance was reduced to almost half (Figure 7B). The inhibition of the open probability fits with the inhibition of Ca2+ entry in T. gondii. In comparison to ACA, benzamil only reduced the open probability of TgTRPPL-2 but not the length of time the channel was open (Figure 7C, D). The conductance of TgTRPPL-2 was reduced to one third of the control in the presence of benzamil.

Figure 7. Transient receptor potential (TRP) inhibitors decreased the activity of TgTRPPL-2.

Figure 7.

(A) Example of currents recorded of TgTRPPL-2-expressing cells at –80 mV without inhibitors (black trace) compared with the currents in the presence of 1 μM of anthranilic acid (ACA) (blue trace) or 10 μM of benzamil (red trace). (B) Calculated open probability of TgTRPPL-2-expressing cells (black) or in the presence of ACA (blue). **p<0.006–0.007. (C) Calculated open probability of TgTRPPL-2-expressing cells (black) or in the presence of benzamil (red). Asterisks indicate p-values for significance. *p<0.02, **p<0.002, ***p<0.0002. (D) Average time of channel opening (dwell time) of TgTRPPL-2-expressing cells in the presence of TRP inhibitors. Asterisks indicate p-values for significance, *p<0.02. (E) Plaque assay of the ΔTgTRPPL-2 mutant and the parental strain in the presence of ACA (1 μM), benzamil (10 μM), and cilnidipine (40 μM) after 7 days of growth. (F) Statistical analysis of plaque sizes done from three independent biological replicates using Student’s t-test. Values are means ± SEM, ****p<0.0001.

Figure 7—source data 1. Inhibition measurements.

Based on the pharmacological results, we predicted that the TRP inhibitors should also inhibit in vitro growth assays (Figure 7E, F, top panel and parental bars). Both ACA and benzamil significantly inhibited in vitro T. gondii growth. We calculated the IC50 for ACA at 1.4 ± 0.4 μM. Consistent with ACA and benzamil targeting TRP channels, neither drug affected the already attenuated growth of the ΔTgTRPPL-2 mutant (Figure 7F). Cilnidipine, a voltage-gated Ca2+ channel blocker, completely inhibited growth of both parental and the ΔTgTRPPL-2 mutant, suggesting that the activity of the L-type Ca2+ channel contributes to the residual growth of the ΔTgTRPPL-2 mutant (Figure 7F).

In conclusion, TgTRPPL-2 is a cation-permeable channel that can be inhibited by broad-spectrum TRP channel inhibitors. Inhibition of channel activity inhibited parasite growth.

Discussion

In this study, we report the presence and functional role of a T. gondii channel, TgTRPPL-2, that localizes to the endoplasmic reticulum and plasma membrane. The corresponding gene TgGT1_310560 was annotated as hypothetical but was predicted as a TRP channel based on a bioinformatic analysis of the T. gondii genome comparing it with TRP channel genes of mammalian origin (Prole and Taylor, 2011). Here, we established that TgTRPPL-2 is important for both Ca2+ entry at the PM and Ca2+ efflux from the ER of T. gondii tachyzoites. TgTRPPL-2, expressed in HEK-3KO cells, conducted currents in high calcium solutions and was not voltage dependent. Interestingly, Ca2+ itself modulated the conductance of TgTRPPL-2. Broad-spectrum TRP channel inhibitors like ACA and benzamil inhibited the activity of TgTRPPL-2, Ca2+ influx in the parasite as well as parasite growth.

Silencing of TgTRPPL-2 in the ΔTgTRPPL-2 mutant impacted both invasion and egress of T. gondii, resulting in a general growth defect. Extracellular tachyzoites, which are surrounded by high Ca2+, are able to use Ca2+ influx to stimulate invasion of a new host cell and carry on their lytic cycle. The ΔTgTRPPL-2 mutant showed a reduction in their host invasion ability, suggesting the defect may be due to a reduction in Ca2+ influx because of the absence of TgTRPPL-2. Interestingly, the reduction in Ca2+ influx (~50%) in the ΔTgTRPPL-2 mutant was comparable to the reduction of invasion, suggesting that TgTRPPL-2 may be involved in the Ca2+ influx pathway that stimulates invasion. Delay in the ability of the ΔTgTRPPL-2 mutant to egress could be caused by a defective efflux of Ca2+ from the ER, which was significantly lower in the mutant. This was evidence for the function of TgTRPPL-2 as a Ca2+ channel at the ER membrane.

The impact of silencing TgTRPPL-2 on T. gondii growth was not total, and parasites were still able to perform lytic cycle activities at a reduced rate. The main defects of the ΔTgTRPPL-2 mutant – invasion, egress, Ca2+ influx, and ER Ca2+ efflux – were not complete likely because more than one mechanism or channel is functional at both locations (PM and ER). We hypothesize the presence of another channel at the PM, likely the one responsible for the Ca2+ influx activity that is inhibited by nifedipine (Pace et al., 2014). It is also possible that a release channel responsive to IP3 may be involved in release of Ca2+ from the ER (Lovett et al., 2002) with TgTRPPL-2 having a role in constitutive efflux and protecting the ER against Ca2+ overload.

Numerous observations in T. gondii have demonstrated that intracellular Ca2+ oscillations in the parasite precede the activation of distinct steps of the lytic cycle (Hortua Triana et al., 2018b; Lourido and Moreno, 2015). Influx of both extracellular and intracellular Ca2+ pools into the parasite cytosol contributes to the activation of downstream signaling pathways decoded into critical biological steps of the parasite lytic cycle (Hortua Triana et al., 2018b; Lovett and Sibley, 2003). Ca2+ influx at the plasma membrane of T. gondii is highly regulated, stimulated by cytosolic Ca2+, and is operational in extracellular (Pace et al., 2014) and intracellular replicating tachyzoites (Vella et al., 2021). Our data with the ΔTgTRPPL-2 mutant identified TgTRPPL-2 as a functional protein at the PM and the ER and in both locations would allow Ca2+ influx into the cytosol. The dual localization of TgTRPPL-2 is in accord with other TRP channels in other cells, which shows a dynamic localization between vesicular organelles and the plasma membrane where they facilitate Ca2+ influx (Bezzerides et al., 2004). In this regard, the human ortholog, PC2, localizes to both the plasma membrane and the ER (Cai et al., 1999).

T. gondii expresses a SERCA-Ca2+-ATPase, a P-type ATPase, that couples ATP hydrolysis to the transport of ions across biological membranes (TgSERCA) and localizes to the ER (Nagamune et al., 2007). TgSERCA is sensitive to Thap, a sesquiterpene lactone derived from the plant Thapsia garganica (Sagara and Inesi, 1991; Thastrup et al., 1990), and previous studies showed that inhibition of TgSERCA by Thap resulted in cytosolic Ca2+ efflux through an unknown channel (Moreno and Zhong, 1996; Pace et al., 2014). In mammalian cells, the passive Ca2+ efflux from the ER is thought to prevent ER Ca2+ overload and help maintain the steady-state concentration of luminal Ca2+ permitting cytosolic Ca2+ signaling (Clapham, 2007; Guerrero-Hernandez et al., 2010). Several membrane proteins have been proposed to be involved in the ER Ca2+ efflux/leak pathway including TRP channels (Carreras-Sureda et al., 2018). Results from this work support a role for TgTRPPL-2 in ER Ca2+ efflux in T. gondii because Ca2+ efflux from the ER caused by the addition of Thap or Zaprinast was significantly decreased in the ΔTgTRPPL-2 mutants. These results support a functional role for TgTRPPL-2 at the membrane of the ER as the constitutive leak channel involved in Ca2+ efflux when the store is filled. This could also be the mechanism by which the ER supplies Ca2+ to other organelles like the mitochondria or the plant-like vacuole (PLV), a lysosome-like compartment that stores Ca2+ (Miranda et al., 2010).

Previous work from our laboratory showed that Ca2+ influx at the plasma membrane does not operate as store-operated Ca2+ entry (SOCE), which was shown with experiments testing surrogate ions like Mn2+ (Pace et al., 2014). This result was supported by the lack of components of the SOCE pathway, STIM, and ORAI from the T. gondii genome (Prole and Taylor, 2011). However, Ca2+ influx was modulated by cytosolic Ca2+ (Pace et al., 2014), and this modulation was absent in the ΔTgTRPPL-2 mutant supporting a role for TgTRPPL-2 as the channel responsible for Ca2+ influx at the PM activated by cytosolic Ca2+. TRP channels have been shown to play a role in Ca2+-activated-Ca2+ entry (Ta et al., 2020). Release of Ca2+ from intracellular stores like the ER is also significantly diminished in the ΔTgTRPPL-2 mutant, which could affect the stimulation of Ca2+ influx. However, when using Zaprinast, which raised cytosolic Ca2+ at a much higher level than Thap, the stimulation of Ca2+ entry by cytosolic Ca2+ was absent. This further supports that TgTRPPL-2 functions at the PM-mediating Ca2+ entry and is modulated by cytosolic Ca2+.

We showed that TgTRPPL-2 was able to conduct currents with conductance values comparable to the values of human TRP channels (Kleene and Kleene, 2017; Liu et al., 2018b; Vien et al., 2020). Previous work with PC2 and other polycystin-like proteins showed that Ca2+ modulated the activity of these proteins (DeCaen et al., 2016; Kuo et al., 2014; Yang et al., 2015Chen et al., 1999; Kleene and Kleene, 2017). Sustained cytosolic Ca2+ increase inhibited PC2-Like1 currents (DeCaen et al., 2016) while other studies showed that cytosolic Ca2+ increase from physiological (100 nM) to μM levels increased the activity of polycystin L and PC2, respectively (Chen et al., 1999; Kleene and Kleene, 2017). We observed some of these responses with TgTRPPL-2 as increasing Ca2+ inside the pipette (affecting the luminal/plasma membrane side of the channel) showed a significant decrease in the currents. Comparably, increasing Ca2+ concentration in the bath solution (cytosolic) from physiological levels to μM levels showed an increase of 2.5× in the conductance of TgTRPPL-2. Although cytosolic [Ca2+] is unlikely to reach those high μM levels, the potential presence of Ca2+ microdomains at the plasma membrane or the ER membrane would result in higher concentrations of Ca2+ at the exit of the channel due to slow diffusion of Ca2+ ions (Berridge, 2006; Burgoyne et al., 2015; Mulier et al., 2017).

Because TRP channels are non-selective cation-permeable channels, they can also permeate monovalent ions like Na+ or K+. When symmetrical KCl was substituted for CsCl, in the presence of Ca2+, we found that TgTRPPL-2 could still conduct cations, strongly indicating Ca2+ permeance. However, we did not determine the ionic preference or selectivity of TgTRPPL-2, thus we can only propose that TgTRPPL-2 is a cation-permeable channel capable of conducting Ca2+. In cilia, PKD channels have been described to have relatively high conductance (Kleene and Kleene, 2017; Liu et al., 2018a). The conductance calculated for TgTRPPL-2 is within range of what has been described for PC2 in other cells (30–157 pS). However, it is important to note that the properties described for any channel will depend on the experimental approaches used.

ACA and benzamil are broad-spectrum inhibitors that have the ability to inhibit TRP channel activity. ACA is a weak base that inhibits currents mediated by TRP channels (Harteneck et al., 2007). ACA does not block the pore of the channel as most inhibitors but rather reduce the open probability of the channel (Harteneck et al., 2007). In a similar manner, benzamil is also able to inhibit currents mediated by TRP channels by binding to a site that modulates their activity rather than blocking its pore (Dai et al., 2007). In our experiments testing ACA and benzamil, we observed that while the inhibitors affected Ca2+ influx and growth of the parental cell line, neither affected the already reduced growth and Ca2+ influx of the ΔTgTRPPL-2 mutant. This result, combined with the inhibition of TgTRPPL-2 currents impacting both open probability and time that the channel remained open, points to TgTRPPL-2 as a target of ACA and benzamil.

Recent studies on Ca2+ signaling in T. gondii have expanded our understanding of the link between Ca2+ and critical facets of parasite biology (i.e., gliding motility, microneme secretion, host cell invasion, and egress) (Borges-Pereira et al., 2015; Brown et al., 2016; Stewart et al., 2017). However, important molecular players have remained enigmatic, like the PM channels responsible for Ca2+ influx and the ER channel responsible for the passive leakage into the cytosol. Characterization of TgTRPPL-2 and its function at the ER and PM fills a small gap in our knowledge of Ca2+ signaling and homeostasis in T. gondii (Figure 8). This study is the first biophysical characterization of a channel in T. gondii, and TgTRPPL-2 represents the first identified molecule to mediate Ca2+ influx into the cytosol of T. gondii at the plasma membrane and the ER. In addition, this study identifies TgTRPPL-2 as a potential target for combatting toxoplasmosis.

Figure 8. Model of the role of TgTRPPL-2 in Ca2+influx into the cytosol of T. gondii.

Figure 8.

Ca2+ entry is mediated by two independent Ca2+ channels at the PM, a nifedipine-sensitive channel (NSC) and TgTRPPL-2. TgTRPPL-2 is a cation-permeable channel that mediates Ca2+ entry at the PM by a pathway that is activated by high [Ca2+] and can be inhibited by broad transient receptor potential inhibitors like anthranilic acid and benzamil. TgA1 is shown as the PM Ca2+ ATPase that pumps Ca2+ outside the cell. TgTRPPL-2 also localizes to the endoplasmic reticulum (ER) where it may function as a Ca2+ efflux channel. Increase in cytosolic [Ca2+] can modulate TgTRPPL-2 by allowing the channel to open for longer time, thus allowing more Ca2+ to enter the cell. Also shown is the IP3-responsive channel in the ER. The molecular identity of this channel is not known. Ca2+ activates the phosphatidyl inositol phospholipase C (PLC), which is also activated through protein kinase G signaling. PLC synthesizes IP3, which stimulates Ca2+ release from the ER.

Materials and methods

Key resources table.

Reagent type
(species) or resource
Designation Source or reference Identifiers Additional
information
Antibody Mouse- αTgTRPPL-2 This work Silvia Moreno (University of Georgia) Recognizes TgGT1_310560 in T. gondii tachyzoites
IFA (1:100)
WB (1:1000)
Antibody Rabbit-αSag1 Mineo et al., 1993 IFA (1:1000)
WB (1:1000)
Antibody Rabbit-αSERCA Nagamune et al., 2007 IFA (1:1,000)
WB (1:1000)
Antibody Rabbit-αGap45 Gaskins et al., 2004 IFA (1:1000)
WB (1:1000)
Antibody Mouse-αTubulin Sigma Aldrich Cat#11867423001 WB (1:10,000)
Antibody Mouse-αHA Roche Cat#11867423001 IFA (1:1000)
Antibody Alexa Fluor 488 Thermo Fisher Scientific Cat#A20181 IFA (1:1000)
Antibody Alexa Fluor 546 Thermo Fisher Scientific Cat#A20183 IFA (1:1000)
Cell line ΔTgTRPPL-2 This work Silvia Moreno (University of Georgia) Clonal cell line with the TgGT1_310560 disrupted
Validated through genomic amplification, qPCR, IFAs, and WB
Cell line TgTRPPL-2-smHA This work Silvia Moreno (University of Georgia) Clonal cell line with the TgGT1_310560 gene locus tagged
Validated through genomic amplification, IFAs, and WB
Cell line ΔTgTRPPL-2-trppl2 This work Silvia Moreno (University of Georgia) Clonal cell line with the TgGT1_310560 disrupted and expressing an extra copy of the same gene
Validated through genomic amplification, qPCR IFAs, and WB
Cell line RHTatiΔku80 Sheiner et al., 2011 Parental line used for tagging
Recombinant DNA reagent TgTRPPL-2-smHA This work Plasmid used to C-terminally tag TgGT1_310560
Recombinant DNA reagent pMOS003-lenti-CMV-gCaMPer Henderson et al., 2015 RRID:Addgene #65227

Toxoplasma growth

All parasite strains were maintained in vitro by serial passage in Dulbecco’s modified minimal essential media (DMEM) with 1% FBS, 2.5 µg/ml amphotericin B, 100 µg/ml streptomycin in the human telomerase reverse transcriptase immortalized foreskin fibroblasts (hTERT) (Farwell et al., 2000). hTert cells are periodically tested and treated for Mycoplasma contamination.

Generation of mutants

The smHA-LIC-CAT plasmid was used for in situ C-terminal tagging of TgTRPPL-2-smHA (Hortua Triana et al., 2018a). Carboxy-terminus tagging was done in the parental line RHTatiΔku80 (TatiΔku80) (Sheiner et al., 2011), a parasite line that contains the tetracyclin-regulated transactivator system that allows conditional expression of genes (Meissner et al., 2001) and also in which the ku80 gene was deleted, increasing efficiency of homologues recombination (Fox et al., 2009). Briefly, a homology region of 974 bp covering the 3′ region of the gene of interest excluding the STOP codon was amplified by PCR using T. gondii RH genomic DNA as template and cloned into the plasmid. Plasmids were validated by restriction digest and sequencing. The oligonucleotides primers used for PCR and for creating the gene-tagging plasmids and for PCR validations are listed in Supplementary file 3 (primers T1–T3). Prior to transfection, all plasmids were linearized within the region of homology. Approximately 20 μg of plasmid DNA was used for transfection of 1 × 107 T. gondii RHTatiΔKu80 parasites using a Gene Pulser X Cell electroporator (BioRad). Selection was done with 20 μM chloramphenicol, and clones were isolated by limiting dilution. DNA of selected clones were isolated and screened by PCR.

To disrupt the TgTRPPL-2 (TgGT1_310560) gene, a single-guide RNA against TgTRPPL-2 was constructed as described (Shen et al., 2017). The single-guide RNA was mutagenized with the desired sequence in a plasmid that contains the Cas9 using the Q5 Mutagenesis Kit following the manufacturer’s instructions. The correct mutation was verified by sequencing. The pyrimethamine-resistant DHFR cassette was amplified by PCR with primers containing 50 bp homology arms of the region upstream and downstream of the start and stop codon of the TgTRPPL-2 gene. The created sgTgTRPPL-2 CRISPR plasmid was co-transfected with the DHFR cassette (3:1, respectively) into RH tachyzoites. Selection followed with pyrimethamine for 7 days. Parasites were sub-cloned by limiting dilution, and screening for clones was done by PCR. The primers used for the creation of the ΔTgTRPPL-2 are listed in Supplementary file 3 (primers K1–K4).

Quantitative PCR

Total RNA from parental, ΔTgTRPPL-2 and ΔTgTRPPL2-trppl2 was extracted and reversed-transcribed into cDNA. The qPCR reaction was done using the iQSYBR Green master mix (BioRad), plus primers, and the reverse-transcribed cDNA (primers shown in Supplementary file 3, Q1–Q2). The qRT-PCR was carried out on a CFX96 PCR Real-Time detection system (C1000Touch Thermal cycler, BioRad). Relative quantification software (CFX Maestro software) was used for the analysis, and relative expression levels were calculated as the fold change using the formula 2ΔΔCT (Livak et al., 1995). Normalization was done using Actin and Tubulin primers. Experiments were repeated three times with triplicate samples.

Antibody production of TgTRPPL-2

The antigenic region for TgTRPPL-2 chosen for antibody production was identified using the IEDB suite of antigenicity prediction software. The DNA sequence was amplified from RH genomic DNA and cloned into the pET-32 LIC/EK vector (Novagen), which adds an N-terminal thioredoxin and histidine tag to the expressed protein. Recombinant CP1Ag was expressed and initially purified via a nickel-affinity column (HisPur Thermo Fisher) as previously described (Chasen et al., 2017). Cleavage of the N-terminal thioredoxin and histidine tag was done by biotinylated thrombin. The antigen was passed again through the nickel column, and the purified tag-less antigen was gently eluted using 10 mM imidazole. Antibodies in mice were generated as previously (Chasen et al., 2019). Swiss Webster mice (Charles River) were inoculated intraperitoneally with 100 μg of TgTRPPL-2 mixed with complete Freund's adjuvant, followed by two boosts with 50 μg of TgTRPPL-2 in incomplete Freund's adjuvant. The final serum was collected by cardiac puncture after CO2 euthanasia. We created a αSERCA antibody for co-localization studies of the TgTRPPL-2. The phosphorylation (P) and nucleotide binding (N) domains of TgSERCA were cloned into XmaI and HindIII sites of pQE-80L plasmid for expression in Escherichia coli BL21-CodonPlus competent cells. Purified antigen was used to immunize Guinea pigs with 0.2 mg of antigen mixed with Freund’s complete adjuvant, followed by two boosts of 0.1 mg antigen mixed with Freund’s incomplete adjuvant (Sigma F5506). The resulting antibodies were used at 1:1000 for western blots. The animal protocol used was approved by the UGA Institutional Animal Care and Use Committee (IACUC).

Western blot analysis

SDS-polyacrylamide gel electrophoresis (SDS-PAGE) followed established protocols (Laemmli, 1970). Lysates were prepared by resuspending a pellet of 1 × 108 tachyzoites in 50 μl of Cell Lytic lysis buffer containing 12.5 U benzonase and 1X protease cocktail inhibitor (P8340 Sigma). The reaction was stopped with one volume of 2% SDS and 1 mM EDTA. Total lysates were boiled in Laemmli sample buffer (BioRad). Immunoblotting followed established protocols using mouse anti-HA monoclonal antibody (1:1000) (Roche). Detection was done using the Odyssey Clx LICOR system using goat anti-mouse IRDye800WC (1:10,000). Loading control for western blots was done with primary mouse-anti-tubulin antibodies at a 1:15,000 dilution and goat anti-mouse IRDDye800WC as secondary (1:10,000).

Immunofluorescence microscopy

Extracellular parasites were collected and purified as previously (Liu et al., 2014). Parasites were washed once with buffer A with glucose (BAG, 116 mM NaCl, 5.4 mM KCl, 0.8 mM MgSO4, 5.5 mM glucose, and 50 mM HEPES, pH 7.4), and an aliquot of 2 × 104 parasites was overlaid on a coverslip previously treated with poly-L-Lysine. Intracellular tachyzoites were grown on hTERT cells on coverslips. Both extracellular and intracellular parasites were fixed with 3% paraformaldehyde for 20 min at room temperature (RT), permeabilized with 0.3% Triton X-100, blocked with 3% bovine serum albumin (BSA), and exposed to primary antibodies (Ratα-HA 1:100). The secondary antibodies used were goat-αrat Alexa Fluor 488 (Life Technologies) at a 1:1000 dilution. For co-localization studies, we used α-Sag1 (1:1000) as membrane marker and α-TgSERCA as ER marker (1:1000). Slides were examined using an Olympus IX-71 inverted fluorescence microscope with a photometric CoolSNAP HQ charge-coupled device (CCD) camera driven by DeltaVision software (Applied Precision, Seattle, WA). Super-resolution images were imaged with a 63× oil (NA 1.4) objective on an 880-laser scanning microscope with Airyscan (Zeiss, Germany) with a 2× zoom. Airyscan images were process with the Zen Black Software (Zeiss, Germany).

Immunoprecipitation assays

Freshly lysed tachyzoites expressing TgTRPPL-2-smHA were collected and filtered through an 8 µM membrane (Whatman). Tachyzoites were washed twice in BAG and resuspended in lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM KCl, 1 mM EDTA, 0.4% NP-40) to a final concentration of 2 × 109 total cells. Lysis was allowed to proceed for 30 min at 4°C, and cells were centrifuged at 15,000 × g for 20 min. Immunoprecipitation of TgTRPPL-2-smHA protein was performed using the Pierce HA Tag/Co-IP Kit (Thermo Fisher Scientific, Waltham, MA) according to the manufacturer’s instructions. Briefly, HA magnetic beads were washed twice in lysis buffer and mixed with the parasite lysate by vortexing for 1 hr at RT. Beads were collected and the flow-through fraction was saved for further analysis. Beads were washed twice in wash buffer (50 mM Tris-HCl, pH 7.4, 150 mM KCl, 1 mM EDTA, 0.1% NP-40) and once in ddH2O by gentle mixing. The tagged protein was recovered by mixing the beads with 1× Laemmli buffer and heated at 65°C for 10 min. The supernatant was collected and used for PAGE and western blots. The corresponding band was cut and resuspended in water and analyzed using LC-Mass Spectrometry. Samples were sent to the Proteomics and Mass Spectrometry Core Facility at the University of Georgia for analysis. The average counts that were obtained from two biological samples are shown in Supplementary file 2. Proteins with counts higher than three are shown.

Growth and invasion assays

Plaque assays were done as previously described, with slight modifications (Liu et al., 2014). Briefly, 200 egressed tachyzoites were allowed to infect confluent hTERT cells for 7 days. After 7 days, cells were fixed with ethanol and stained with crystal violet. Plaque sizes were analyzed using FIJI (Schindelin et al., 2012). Invasion assays were performed as previously described, with slight modifications (Kafsack et al., 2004). A subconfluent monolayer of HFF cells was infected with 2 × 107 tachyzoites in the presence of 1.8 mM or 0.5 mM Ca2+ and placed for 20 min on ice and subsequently transferred for 5 min to a 37°C water bath for parasite invasion. Cells were immediately fixed with 3% paraformaldehyde for 20 min. Extracellular parasites (attached) were stained using RabbitαSag1 (1:1000) prior to permeabilization while intracellular parasites (invaded) were stained with MouseαSag1 (1:200). Secondary antibodies were goat-αrabbit Alexa Fluor 546 (1:1000) and goat-αmouse Alexa Fluor 488 (1:1000). Images were taken with an Olympus IX-71 inverted fluorescence microscope with a Photometric CoolSNAP HQ CCD camera driven by DeltaVision software (Applied Precision). Quantification was made of 10 fields of view at a 1000 magnification from three independent biological replicates. Percentage of invaded versus attached was quantified by dividing the number of parasites invaded or attached by the total parasites quantified in the field of view.

Egress experiments

hTERT cells were infected with 5 × 105 of RH or ΔTgTRPPL-2 tachyzoites. 24 hr after infection, parasitophorous vacuoles (PVs) were observed by microscopy and washed with Ringer’s buffer (155 mM NaCl, 3 mM KCl, 1 mM MgCl2, 3 mM NaH2PO4H2O, 10 mM HEPES, pH 7.3, and 5 mM glucose). Ringer’s buffer was used as extracellular buffer in the presence or absence of 1.8 mM Ca2+. Drugs were added in Ringer’s buffer 30 s after imaging at the following concentrations: saponin (0.02%) or Zaprinast (100 μM). Images were acquired in a time-lapse mode with an acquisition rate of 3 s for 12–20 min. For statistical analysis, egress time was quantified as the first parasite to egress out of the PV. Statistical analysis was done for three independent biological replicates and at least 5 PVs per experiment.

Cytosolic Ca2+measurements

Parasites were loaded with Fura-2-AM as described in Stasic et al., 2021; Vella et al., 2019. Briefly, fresh lysed extracellular tachyzoites were washed twice at 1800 rpm for 10 min at room temperature in buffer A (BAG) (116 mM NaCl, 5.4 mM KCl, 0.8 mM MgSO4, 5.5 mM d-glucose, and 50 mM HEPES, pH 7.4). Parasites were resuspended to a final density of 1 × 109 parasites/ml in loading buffer (Ringer’s plus 1.5% sucrose and 5 μM Fura-2-AM). The suspension was incubated for 26 min at 26°C with mild agitation. Subsequently, the parasites were washed twice with Ringer’s buffer to remove extracellular dye. Parasites were resuspended to a final density of 1 × 109 parasites/ml in Ringer’s buffer and kept in ice. For fluorescence measurements, 2 × 107 parasites/ml were placed in a cuvette with 2.5 ml of Ringer’s buffer. The cuvette was placed in a thermostatically controlled Hitachi F-7000 fluorescence spectrophotometer. Excitation was at 340 and 380 nm, and emission at 510 nm. The Fura-2-AM fluorescence relationship to intracellular Ca2+ concentration ([Ca2+]i) was calibrated from the ratio of 340/380 nm fluorescence values after subtraction of the background fluorescence of the cells at 340 and 380 nm as previously described (Grynkiewicz et al., 1985). Changes in [Ca2+]i (ΔF [Ca2+]) were measured by subtracting the highest peak of Ca2+ in the first 20 s after addition of Ca2+ or 100 s after the addition of drugs minus the baseline.

Cell transfections and culture of HEK-3KO cells

Total RNA of wild-type T. gondii were extracted and reversed transcribed into cDNA. TgTRPPL-2 whole cDNA was amplified using primers shown in Supplementary file 3 (primers C1–C6). The amplified cDNA was cloned into the Zero Blunt TOPO vector using the cloning kit as per the manufacturer's instruction. Correct insertion was verified by colony PCR using M13F and M13R primers. Restriction digests was performed to remove the insert from the vector using the following restriction enzymes: BamHI and AvrII. The purified TgTRPPL-2 cDNA was ligated to linearized pCDNA 3.1 plasmid. Ligation to the vector was confirmed by PCR and sequencing. Purified TRPPL-2-pCDNA was used to co-transfect HEK-3KO cells.

Human embryonic kidney (HEK) cells, which have the three endogenous isoforms of the IP3 receptor knocked out, were a gift from Dr. David Yule (Alzayady et al., 2016; Lock et al., 2018). The cells were maintained in DMEM with 10% fetal bovine serum 2.5 µg/ml amphotericin B and 100 µg/ml streptomycin. They are periodically checked for Mycoplasma contamination. Cells were transiently transfected as previously described (Longo et al., 2013) with 2.5 μg of TgTRPPL-2, PC2, or RFP DNA targeted to the ER. Each plasmid DNA were diluted in 200 μl of Opti-MEM with 25 μl of polyethylenimine and incubated for 10 min. The mix was then added to semi-confluent HEK-3KO cells in a dropwise manner, and 24 hr later the media was changed.

Preparation of nuclear extracts

48 hr after transfection, cells were collected and the nucleus extracted as previously described (Mak et al., 2013a). 2 × 107 of transiently transfected cells were collected in ice-cold PBS. Cells were spun down and washed twice in PBS and resuspended in Nuclei Isolation Solution (150 mM KCl, 250 mM sucrose, 10 mM Tris-HCl, 1.4 mM β-mercaptoethanol, 0.2 mM PMSF, pH 7.3). Cells were dounce homogenized and nuclei extracts stored on ice. 100 μl of nuclei were transferred to cover slips previously coated with poly-L-lysine and incubated for 20 min before filling the chamber with bath solution.

Patch clamp of nuclear membranes

Nuclear extracts expressing TgTRPPL-2 or the control with gCaMPer (Henderson et al., 2015) were used for analysis. Currents were recorded using electrodes pulled from filamented borosilicate capillary glass (Harvard Bioscience, MA) with a resistance of 10–15 MΩ. After forming the seal and pulling the outside (cytosolic-side) out, membrane patch configurations (Mak et al., 2013b) holding potentials were maintained at 0 mV. Recordings were obtained using the HEKA Electronic Patch Clamp EPC10 (Harvard Bioscience). The internal solution contained (mM) 140 KCl or CsCl, 10 HEPES, 1.8 or 10 free Ca2+ adjusted with EGTA. The Standard Bath Solution was symmetrical to the pipette solution except there was 100 nM or 10 µM of free Ca2+. Currents were elicited by applying voltage steps from the holding potential of 0 mV and stepping down to −80 mV and then up to 20 mV over 25 s. Data was acquired at 45 kHz and filtered at 2 kHz. Each voltage sweep was conducted a total of five times. Analysis of current amplitude, channel open probability, and channel conductance was conducted using FitMaster (Harvard Bioscience). Conductance was calculated by plotting the current-voltage relationship for each condition tested and then determining the slope conductance between −80 to +20 mV. gCaMPer fluorescent signals were simultaneously analyzed as the current signals in preparations where the ER was broken into. A Lumencor LED light source switching between 488 and 561 nm was used to excite the samples, and the fluorescent signals captured on a Hamamatsu Flash 4.0 cMOS camera using Zeiss Zen Black software.

Statistics

Statistical analyses were performed by Student’s t-test using GraphPad PRISM version 8.2. All experimental data were analyzed from at least three independent biological replicates. Error bars shown represent standard error of the mean (SEM) of the biological replicates analyzed. For the electrophysiological analysis, a total of three cells per biological replicate (nine total cells) were analyzed.

Acknowledgements

 We thank Drs. David Yule for providing the HEK-3KO cells for electrophysiological analyses, John Boothroyd for antibodies against SAG1, and Boris Striepen for providing us with the Cosmid for complementation. We thank Catherine Li for generating the antigen used to generate the anti-SERCA antibody. The super-resolution microscope is part of the Biomedical Microscopy Core (BMC) of the University of Georgia, which is directed by Dr. MK Kandasamy. We thank the University of Georgia Graduate School for awarding a Summer Research Travel Grant to KMMN. This work was supported by the U.S. National Institutes of Health grants AI154931 and AI128356 to SNJM and R00 DK101585 to IYK. KMMN was partially supported through a fellowship funded by a T32 training grant, 5T32AI060546.

Funding Statement

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Contributor Information

Silvia NJ Moreno, Email: smoreno@uga.edu.

Malcolm J McConville, The University of Melbourne, Australia.

Dominique Soldati-Favre, University of Geneva, Switzerland.

Funding Information

This paper was supported by the following grants:

  • National Institutes of Health AI154931 to Silvia NJ Moreno.

  • National Institutes of Health AI128356 to Silvia NJ Moreno.

  • National Institutes of Health T32AI060546 to Karla Marie Márquez-Nogueras.

  • National Institutes of Health DK101585 to Ivana Y Kuo.

Additional information

Competing interests

No competing interests declared.

Author contributions

Conceptualization, Validation, Investigation, Methodology, Writing - original draft, Writing - review and editing.

Formal analysis, Investigation, Methodology.

Resources, Investigation.

Conceptualization, Resources, Supervision, Funding acquisition, Methodology, Writing - review and editing.

Conceptualization, Resources, Supervision, Funding acquisition, Project administration, Writing - review and editing.

Additional files

Source data 1. Original blots.
Supplementary file 1. Top 10 hits resulting from the analysis of the TgGT1_310560 gene with the HHPRED server.
elife-63417-supp1.docx (14.8KB, docx)
Supplementary file 2. Mass spectrometry results of the sliced band after immunoprecipitation of TgTRPPL-2.
elife-63417-supp2.docx (14.4KB, docx)
Supplementary file 3. Primers used in this work.
elife-63417-supp3.docx (14.6KB, docx)
Supplementary file 4. Composition of the solutions used for the electrophysiological analysis.
elife-63417-supp4.docx (13.9KB, docx)
Transparent reporting form

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files.

References

  1. Almog M, Korngreen A. Characterization of voltage-gated ca(2+) conductances in layer 5 neocortical pyramidal neurons from rats. PLOS ONE. 2009;4:e4841. doi: 10.1371/journal.pone.0004841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alzayady KJ, Wang L, Chandrasekhar R, Wagner LE, Van Petegem F, Yule DI. Defining the stoichiometry of inositol 1,4,5-trisphosphate binding required to initiate Ca2+ release. Science Signaling. 2016;9:ra35. doi: 10.1126/scisignal.aad6281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Berridge MJ, Bootman MD, Roderick HL. Calcium signalling: dynamics, homeostasis and remodelling. Nature Reviews Molecular Cell Biology. 2003;4:517–529. doi: 10.1038/nrm1155. [DOI] [PubMed] [Google Scholar]
  4. Berridge MJ. Calcium microdomains: organization and function. Cell Calcium. 2006;40:405–412. doi: 10.1016/j.ceca.2006.09.002. [DOI] [PubMed] [Google Scholar]
  5. Bezzerides VJ, Ramsey IS, Kotecha S, Greka A, Clapham DE. Rapid vesicular translocation and insertion of TRP channels. Nature Cell Biology. 2004;6:709–720. doi: 10.1038/ncb1150. [DOI] [PubMed] [Google Scholar]
  6. Black MW, Boothroyd JC. Lytic cycle of Toxoplasma gondii. Microbiology and Molecular Biology Reviews : MMBR. 2000;64:607–623. doi: 10.1128/MMBR.64.3.607-623.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Blader IJ, Coleman BI, Chen CT, Gubbels MJ. Lytic cycle of Toxoplasma gondii: 15 years later. Annual Review of Microbiology. 2015;69:463–485. doi: 10.1146/annurev-micro-091014-104100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Borges-Pereira L, Budu A, McKnight CA, Moore CA, Vella SA, Hortua Triana MA, Liu J, Garcia CRS, Pace DA, Moreno SNJ. Calcium signaling throughout the Toxoplasma gondii lytic cycle: a STUDY USING GENETICALLY ENCODED CALCIUM INDICATORS. The Journal of Biological Chemistry. 2015;290:26914–26926. doi: 10.1074/jbc.M115.652511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Boucher C, Sandford R. Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2) European Journal of Human Genetics. 2004;12:347–354. doi: 10.1038/sj.ejhg.5201162. [DOI] [PubMed] [Google Scholar]
  10. Brown KM, Lourido S, Sibley LD. Serum albumin stimulates protein kinase G-dependent microneme secretion in Toxoplasma gondii. Journal of Biological Chemistry. 2016;291:9554–9565. doi: 10.1074/jbc.M115.700518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Burgoyne T, Patel S, Eden ER. Calcium signaling at ER membrane contact sites. Biochimica Et Biophysica Acta (BBA) - Molecular Cell Research. 2015;1853:2012–2017. doi: 10.1016/j.bbamcr.2015.01.022. [DOI] [PubMed] [Google Scholar]
  12. Cai Y, Maeda Y, Cedzich A, Torres VE, Wu G, Hayashi T, Mochizuki T, Park JH, Witzgall R, Somlo S. Identification and characterization of polycystin-2, the PKD2 gene product. Journal of Biological Chemistry. 1999;274:28557–28565. doi: 10.1074/jbc.274.40.28557. [DOI] [PubMed] [Google Scholar]
  13. Carreras-Sureda A, Pihán P, Hetz C. Calcium signaling at the endoplasmic reticulum: fine-tuning stress responses. Cell Calcium. 2018;70:24–31. doi: 10.1016/j.ceca.2017.08.004. [DOI] [PubMed] [Google Scholar]
  14. Celić A, Petri ET, Demeler B, Ehrlich BE, Boggon TJ. Domain mapping of the polycystin-2 C-terminal tail using de novo molecular modeling and biophysical analysis. Journal of Biological Chemistry. 2008;283:28305–28312. doi: 10.1074/jbc.M802743200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Chasen NM, Asady B, Lemgruber L, Vommaro RC, Kissinger JC, Coppens I, Moreno SNJ. A Glycosylphosphatidylinositol-Anchored carbonic Anhydrase-Related protein of Toxoplasma gondii Is Important for Rhoptry Biogenesis and Virulence. mSphere. 2017;2:e00027-17. doi: 10.1128/mSphere.00027-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Chasen NM, Stasic AJ, Asady B, Coppens I, Moreno SNJ. The vacuolar zinc transporter TgZnT protects Toxoplasma gondii from zinc toxicity. mSphere. 2019;4:e00086-19. doi: 10.1128/mSphere.00086-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Chen XZ, Vassilev PM, Basora N, Peng JB, Nomura H, Segal Y, Brown EM, Reeders ST, Hediger MA, Zhou J. Polycystin-L is a calcium-regulated cation channel permeable to calcium ions. Nature. 1999;401:383–386. doi: 10.1038/43907. [DOI] [PubMed] [Google Scholar]
  18. Clapham DE. Calcium signaling. Cell. 2007;131:1047–1058. doi: 10.1016/j.cell.2007.11.028. [DOI] [PubMed] [Google Scholar]
  19. Dai XQ, Ramji A, Liu Y, Li Q, Karpinski E, Chen XZ. Inhibition of TRPP3 channel by amiloride and analogs. Molecular Pharmacology. 2007;72:1576–1585. doi: 10.1124/mol.107.037150. [DOI] [PubMed] [Google Scholar]
  20. DeCaen PG, Liu X, Abiria S, Clapham DE. Atypical calcium regulation of the PKD2-L1 polycystin ion channel. eLife. 2016;5:e13413. doi: 10.7554/eLife.13413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Farwell DG, Shera KA, Koop JI, Bonnet GA, Matthews CP, Reuther GW, Coltrera MD, McDougall JK, Klingelhutz AJ. Genetic and epigenetic changes in human epithelial cells immortalized by telomerase. The American Journal of Pathology. 2000;156:1537–1547. doi: 10.1016/S0002-9440(10)65025-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Fox BA, Ristuccia JG, Gigley JP, Bzik DJ. Efficient gene replacements in Toxoplasma gondii strains deficient for nonhomologous end joining. Eukaryotic Cell. 2009;8:520–529. doi: 10.1128/EC.00357-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Gaskins E, Gilk S, DeVore N, Mann T, Ward G, Beckers C. Identification of the membrane receptor of a class XIV myosin in Toxoplasma gondii. Journal of Cell Biology. 2004;165:383–393. doi: 10.1083/jcb.200311137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. Journal of Biological Chemistry. 1985;260:3440–3450. doi: 10.1016/S0021-9258(19)83641-4. [DOI] [PubMed] [Google Scholar]
  25. Guerrero-Hernandez A, Dagnino-Acosta A, Verkhratsky A. An intelligent sarco-endoplasmic reticulum Ca2+ store: release and leak channels have differential access to a concealed Ca2+ pool. Cell Calcium. 2010;48:143–149. doi: 10.1016/j.ceca.2010.08.001. [DOI] [PubMed] [Google Scholar]
  26. Harteneck C, Frenzel H, Kraft R. N-(p-amylcinnamoyl)anthranilic acid (ACA): a phospholipase A(2) inhibitor and TRP channel blocker. Cardiovascular Drug Reviews. 2007;25:61–75. doi: 10.1111/j.1527-3466.2007.00005.x. [DOI] [PubMed] [Google Scholar]
  27. Henderson MJ, Baldwin HA, Werley CA, Boccardo S, Whitaker LR, Yan X, Holt GT, Schreiter ER, Looger LL, Cohen AE, Kim DS, Harvey BK. A low affinity GCaMP3 variant (GCaMPer) for imaging the endoplasmic reticulum calcium store. PLOS ONE. 2015;10:e0139273. doi: 10.1371/journal.pone.0139273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Hortua Triana MA, Márquez-Nogueras KM, Chang L, Stasic AJ, Li C, Spiegel KA, Sharma A, Li ZH, Moreno SNJ. Tagging of weakly expressed Toxoplasma gondii Calcium-Related genes with High-Affinity tags. Journal of Eukaryotic Microbiology. 2018a;65:709–721. doi: 10.1111/jeu.12626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Hortua Triana MA, Márquez-Nogueras KM, Vella SA, Moreno SNJ. Calcium signaling and the lytic cycle of the apicomplexan parasite Toxoplasma gondii. Biochimica Et Biophysica Acta (BBA) - Molecular Cell Research. 2018b;1865:1846–1856. doi: 10.1016/j.bbamcr.2018.08.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Kafsack BF, Beckers C, Carruthers VB. Synchronous invasion of host cells by Toxoplasma gondii. Molecular and Biochemical Parasitology. 2004;136:309–311. doi: 10.1016/j.molbiopara.2004.04.004. [DOI] [PubMed] [Google Scholar]
  31. Kleene SJ, Kleene NK. The native TRPP2-dependent channel of murine renal primary cilia. American Journal of Physiology-Renal Physiology. 2017;312:F96–F108. doi: 10.1152/ajprenal.00272.2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Koulen P, Cai Y, Geng L, Maeda Y, Nishimura S, Witzgall R, Ehrlich BE, Somlo S. Polycystin-2 is an intracellular calcium release channel. Nature Cell Biology. 2002;4:191–197. doi: 10.1038/ncb754. [DOI] [PubMed] [Google Scholar]
  33. Kuo IY, Keeler C, Corbin R, Ćelić A, Petri ET, Hodsdon ME, Ehrlich BE. The number and location of EF hand motifs dictates the calcium dependence of polycystin‐2 function. The FASEB Journal. 2014;28:2332–2346. doi: 10.1096/fj.13-247106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  35. Liu J, Pace D, Dou Z, King TP, Guidot D, Li ZH, Carruthers VB, Moreno SN. A vacuolar-H(+) -pyrophosphatase (TgVP1) is required for microneme secretion, host cell invasion, and extracellular survival of Toxoplasma gondii. Molecular Microbiology. 2014;93:698–712. doi: 10.1111/mmi.12685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Liu X, Ong H, Ambudkar I. TRP channel involvement in salivary Glands—Some Good, Some Bad. Cells. 2018a;7:74. doi: 10.3390/cells7070074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Liu X, Vien T, Duan J, Sheu SH, DeCaen PG, Clapham DE. Polycystin-2 is an essential ion channel subunit in the primary cilium of the renal collecting duct epithelium. eLife. 2018b;7:e33183. doi: 10.7554/eLife.33183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Livak KJ, Flood SJ, Marmaro J, Giusti W, Deetz K. Oligonucleotides with fluorescent dyes at Opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. Genome Research. 1995;4:357–362. doi: 10.1101/gr.4.6.357. [DOI] [PubMed] [Google Scholar]
  39. Lock JT, Alzayady KJ, Yule DI, Parker I. All three IP3 receptor isoforms generate Ca2+ puffs that display similar characteristics. Science Signaling. 2018;11:eaau0344. doi: 10.1126/scisignal.aau0344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Longo PA, Kavran JM, Kim MS, Leahy DJ. Transient mammalian cell transfection with polyethylenimine (PEI) Methods in Enzymology. 2013;529:227–240. doi: 10.1016/B978-0-12-418687-3.00018-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Lourido S, Moreno SN. The calcium signaling toolkit of the apicomplexan parasites Toxoplasma gondii and plasmodium spp. Cell Calcium. 2015;57:186–193. doi: 10.1016/j.ceca.2014.12.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Lovett JL, Marchesini N, Moreno SN, Sibley LD. Toxoplasma gondii microneme secretion involves intracellular ca(2+) release from inositol 1,4,5-triphosphate (IP(3))/ryanodine-sensitive stores. Journal of Biological Chemistry. 2002;277:25870–25876. doi: 10.1074/jbc.M202553200. [DOI] [PubMed] [Google Scholar]
  43. Lovett JL, Sibley LD. Intracellular calcium stores in Toxoplasma gondii govern invasion of host cells. Journal of Cell Science. 2003;116:3009–3016. doi: 10.1242/jcs.00596. [DOI] [PubMed] [Google Scholar]
  44. Mak DO, Vais H, Cheung KH, Foskett JK. Nuclear patch-clamp electrophysiology of Ca2+ channels. Cold Spring Harbor Protocols. 2013a;2013:885–891. doi: 10.1101/pdb.prot073064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Mak DO, Vais H, Cheung KH, Foskett JK. Patch-clamp electrophysiology of intracellular Ca2+ channels. Cold Spring Harbor Protocols. 2013b;2013:787–797. doi: 10.1101/pdb.top066217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Meissner M, Brecht S, Bujard H, Soldati D. Modulation of myosin A expression by a newly established tetracycline repressor-based inducible system in Toxoplasma gondii. Nucleic Acids Research. 2001;29:E115. doi: 10.1093/nar/29.22.e115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Merrick D, Bertuccio CA, Chapin HC, Lal M, Chauvet V, Caplan MJ. Polycystin-1 cleavage and the regulation of transcriptional pathways. Pediatric Nephrology. 2014;29:505–511. doi: 10.1007/s00467-013-2548-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Mineo JR, McLeod R, Mack D, Smith J, Khan IA, Ely KH, Kasper LH. Antibodies to Toxoplasma gondii major surface protein (SAG-1, P30) inhibit infection of host cells and are produced in murine intestine after peroral infection. The Journal of Immunology. 1993;150:3951–3964. [PubMed] [Google Scholar]
  49. Miranda K, Pace DA, Cintron R, Rodrigues JC, Fang J, Smith A, Rohloff P, Coelho E, de Haas F, de Souza W, Coppens I, Sibley LD, Moreno SN. Characterization of a novel organelle in Toxoplasma gondii with similar composition and function to the plant vacuole. Molecular Microbiology. 2010;76:1358–1375. doi: 10.1111/j.1365-2958.2010.07165.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Montell C. The TRP superfamily of cation channels. Science Signaling. 2005;2005:re3. doi: 10.1126/stke.2722005re3. [DOI] [PubMed] [Google Scholar]
  51. Moreno SN, Zhong L. Acidocalcisomes in Toxoplasma gondii tachyzoites. Biochemical Journal. 1996;313:655–659. doi: 10.1042/bj3130655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Mulier M, Vriens J, Voets T. TRP channel pores and local calcium signals. Cell Calcium. 2017;66:19–24. doi: 10.1016/j.ceca.2017.04.007. [DOI] [PubMed] [Google Scholar]
  53. Nagamune K, Beatty WL, Sibley LD. Artemisinin induces calcium-dependent protein secretion in the protozoan parasite Toxoplasma gondii. Eukaryotic Cell. 2007;6:2147–2156. doi: 10.1128/EC.00262-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Nilius B, Owsianik G. The transient receptor potential family of ion channels. Genome Biology. 2011;12:218. doi: 10.1186/gb-2011-12-3-218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Omasits U, Ahrens CH, Müller S, Wollscheid B. Protter: interactive protein feature visualization and integration with experimental proteomic data. Bioinformatics. 2014;30:884–886. doi: 10.1093/bioinformatics/btt607. [DOI] [PubMed] [Google Scholar]
  56. Pace DA, McKnight CA, Liu J, Jimenez V, Moreno SN. Calcium entry in Toxoplasma gondii and its enhancing effect of invasion-linked traits. Journal of Biological Chemistry. 2014;289:19637–19647. doi: 10.1074/jbc.M114.565390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Petri ET, Celic A, Kennedy SD, Ehrlich BE, Boggon TJ, Hodsdon ME. Structure of the EF-hand domain of polycystin-2 suggests a mechanism for Ca2+-dependent regulation of polycystin-2 channel activity. PNAS. 2010;107:9176–9181. doi: 10.1073/pnas.0912295107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Prole DL, Taylor CW. Identification of intracellular and plasma membrane calcium channel homologues in pathogenic parasites. PLOS ONE. 2011;6:e26218. doi: 10.1371/journal.pone.0026218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Sagara Y, Inesi G. Inhibition of the sarcoplasmic reticulum Ca2+ transport ATPase by thapsigargin at Subnanomolar concentrations. Journal of Biological Chemistry. 1991;266:13503–13506. doi: 10.1016/S0021-9258(18)92726-2. [DOI] [PubMed] [Google Scholar]
  60. Samanta A, Hughes TET, Moiseenkova-Bell VY. Transient receptor potential (TRP) Channels. Sub-Cellular Biochemistry. 2018;87:141–165. doi: 10.1007/978-981-10-7757-9_6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez JY, White DJ, Hartenstein V, Eliceiri K, Tomancak P, Cardona A. Fiji: an open-source platform for biological-image analysis. Nature Methods. 2012;9:676–682. doi: 10.1038/nmeth.2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Sheiner L, Demerly JL, Poulsen N, Beatty WL, Lucas O, Behnke MS, White MW, Striepen B. A systematic screen to discover and analyze apicoplast proteins identifies a conserved and essential protein import factor. PLOS Pathogens. 2011;7:e1002392. doi: 10.1371/journal.ppat.1002392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Shen B, Brown K, Long S, Sibley LD. Development of CRISPR/Cas9 for efficient genome editing in Toxoplasma gondii. Methods in Molecular Biology. 2017;1498:79–103. doi: 10.1007/978-1-4939-6472-7_6. [DOI] [PubMed] [Google Scholar]
  64. Sidik SM, Hortua Triana MA, Paul AS, El Bakkouri M, Hackett CG, Tran F, Westwood NJ, Hui R, Zuercher WJ, Duraisingh MT, Moreno SN, Lourido S. Using a genetically encoded sensor to identify inhibitors of Toxoplasma gondii Ca2+ signaling. Journal of Biological Chemistry. 2016;291:9566–9580. doi: 10.1074/jbc.M115.703546. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Söding J. Protein homology detection by HMM-HMM comparison. Bioinformatics. 2005;21:951–960. doi: 10.1093/bioinformatics/bti125. [DOI] [PubMed] [Google Scholar]
  66. Stasic AJ, Dykes EJ, Cordeiro CD, Vella SA, Fazli MS, Quinn S, Docampo R, Moreno SNJ. Ca2+ entry at the plasma membrane and uptake by acidic stores is regulated by the activity of the V-H+ -ATPase in Toxoplasma gondii. Molecular Microbiology. 2021 doi: 10.1111/mmi.14722. In press. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Stewart RJ, Whitehead L, Nijagal B, Sleebs BE, Lessene G, McConville MJ, Rogers KL, Tonkin CJ. Analysis of ca(2)(+) mediated signaling regulating Toxoplasma infectivity reveals complex relationships between key molecules. Cellular Microbiology. 2017;19:12685. doi: 10.1111/cmi.12685. [DOI] [PubMed] [Google Scholar]
  68. Ta CM, Vien TN, Ng LCT, DeCaen PG. Structure and function of polycystin channels in primary cilia. Cellular Signalling. 2020;72:109626. doi: 10.1016/j.cellsig.2020.109626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Thastrup O, Cullen PJ, Drøbak BK, Hanley MR, Dawson AP. Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase. PNAS. 1990;87:2466–2470. doi: 10.1073/pnas.87.7.2466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Vella SA, Calixto A, Asady B, Li ZH, Moreno SN. Genetic indicators for calcium signaling studies in Toxoplasma gondii. Methods in Molecular Biology Toxoplasma. 2019;2071:187–207. doi: 10.1007/978-1-4939-9857-9_11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Vella SA, Moore CA, Li ZH, Hortua Triana MA, Potapenko E, Moreno SNJ. The role of potassium and host calcium signaling in Toxoplasma gondii egress. Cell Calcium. 2021;94:102337. doi: 10.1016/j.ceca.2020.102337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Venkatachalam K, Montell C. TRP channels. Annual Review of Biochemistry. 2007;76:387–417. doi: 10.1146/annurev.biochem.75.103004.142819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Vien TN, Wang J, Ng LCT, Cao E, DeCaen PG. Molecular dysregulation of ciliary polycystin-2 channels caused by variants in the TOP domain. PNAS. 2020;117:10329–10338. doi: 10.1073/pnas.1920777117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Vinayak S, Brooks CF, Naumov A, Suvorova ES, White MW, Striepen B. Genetic manipulation of the Toxoplasma gondii genome by fosmid recombineering. mBio. 2014;5:e02021. doi: 10.1128/mBio.02021-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Wang Z, Ng C, Liu X, Wang Y, Li B, Kashyap P, Chaudhry HA, Castro A, Kalontar EM, Ilyayev L, Walker R, Alexander RT, Qian F, Chen XZ, Yu Y. The ion channel function of polycystin-1 in the polycystin-1/polycystin-2 complex. EMBO Reports. 2019;20:e48336. doi: 10.15252/embr.201948336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Weiss LM, Dubey JP. Toxoplasmosis: a history of clinical observations. International Journal for Parasitology. 2009;39:895–901. doi: 10.1016/j.ijpara.2009.02.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Wolstenholme AJ, Williamson SM, Reaves BJ. TRP channels in parasites. Advances in Experimental Medicine and Biology. 2011;704:359–371. doi: 10.1007/978-94-007-0265-3_20. [DOI] [PubMed] [Google Scholar]
  78. Wu LG, Westenbroek RE, Borst JG, Catterall WA, Sakmann B. Calcium channel types with distinct presynaptic localization couple differentially to transmitter release in single calyx-type synapses. The Journal of Neuroscience. 1999;19:726–736. doi: 10.1523/JNEUROSCI.19-02-00726.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Yang Y, Keeler C, Kuo IY, Lolis EJ, Ehrlich BE, Hodsdon ME. Oligomerization of the polycystin-2 C-terminal tail and effects on its Ca2+-binding properties. Journal of Biological Chemistry. 2015;290:10544–10554. doi: 10.1074/jbc.M115.641803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Zhou J. Polycystins and primary cilia: primers for cell cycle progression. Annual Review of Physiology. 2009;71:83–113. doi: 10.1146/annurev.physiol.70.113006.100621. [DOI] [PubMed] [Google Scholar]

Decision letter

Editor: Malcolm J McConville1
Reviewed by: Malcolm J McConville2, Andrew Thomas3

In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

Acceptance summary:

This work identifies a Transient Receptor Potential (TRP) channel that regulates calcium signalling in the parasitic protist, Toxoplasma gondii. The TgTRPPL-2 protein localizes to both the plasma membrane and endoplasmic reticulum and has important roles in regulating influx of extracellular calcium, the release of intracellular calcium stores and key steps in parasite invasion and egress from host cells. The parasite channel is sensitive to broad spectrum TRP channel inhibitors suggesting that TgTRRPL-2 is a druggable target.

Decision letter after peer review:

Thank you for submitting your article "Calcium signaling through a Transient Receptor Channel is important for Toxoplasma gondii growth" for consideration by eLife. Your article has been reviewed by 3 peer reviewers, including Malcolm J McConville as the Reviewing Editor and Reviewer #1, and the evaluation has been overseen by Dominique Soldati-Favre as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Andrew Thomas (Reviewer #2) and Mathieu Brochet and Aurélia Balestra (Reviewer #3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

As the editors have judged that your manuscript is of interest, but as described below that additional experiments are required before it is published, we would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). First, because many researchers have temporarily lost access to the labs, we will give authors as much time as they need to submit revised manuscripts. We are also offering, if you choose, to post the manuscript to bioRxiv (if it is not already there) along with this decision letter and a formal designation that the manuscript is "in revision at eLife". Please let us know if you would like to pursue this option. (If your work is more suitable for medRxiv, you will need to post the preprint yourself, as the mechanisms for us to do so are still in development.)

Summary:

This paper provides strong evidence that a putative Toxoplasma gondii TRP cation channel protein, TgTRPPL-2, mediates calcium influx at the plasma membrane and calcium efflux in the ER. The dual localization of both epitope-tagged and native TgTRPPL protein to the PM and ER was assessed by microscopy, while phenotypic analysis of a ∆TgTRPPL-2 parasite line indicated that the channel is required for parasite invasion and egress in vitro. Calcium transport activity was measured using patch-clamp techniques in HEK3KO cells expressing TfTRPPL-2 as well as the use of well-defined inhibitors. The findings add to our current understanding of calcium signalling in these evolutionarily divergent eukaryotes, which has been shown by many studies to underpin many signalling and differentiation events in the T. gondii life cycle.

Essential revisions:

1. The localization of epitope-tagged and native TgTRPPL-2 to the ER is compelling. However, the evidence for plasma membrane localization is not as clear and should be supported by additional evidence (including higher resolution images) and/or more careful discussion. In particular, can the authors discount the possibility that TgTRPPL-2 also localizes to the IMC, which has the potential to be a calcium store.

2. The authors need to further clarify their gene/protein model and better justify their proposal that TgTRPPL is cleaved into two proteins/protein isoforms in vivo. Specifically, do the authors have any evidence of different sized proteins in parasite lines expressing epitope tagged proteins or from using antibodies to the native protein(s)?

3. The authors should clarify the reverse genetic strategy and the experimental conditions used to phenotype the parasites. In particular, while Figure 2A and the text suggest a disruption of trppl2, the method indicates a full deletion. A clear figure depicting the strategy and showing genotyping should be included.

4. The authors propose that nifedipine increases basal cytosolic Ca2+ selectively in the in ΔTgTRPPL-2 mutant (Figure 6B) by increasing leakage from intracellular Ca2+ stores as a means to compensate for the absence of plasma membrane Ca2+ influx. However, it is unclear how the absence of plasma membrane Ca2+ entry could couple to enhanced leak from intracellular stores. Moreover, there is no mechanistic explanation for why sensitivity to nifedipine is lost in ΔTgTRPPL-2 and then restored in the complemented mutant (Figure 6D). The authors should further qualify this hypothesis or remove it.

eLife. 2021 Jun 9;10:e63417. doi: 10.7554/eLife.63417.sa2

Author response


Essential revisions:

1. The localization of epitope-tagged and native TgTRPPL-2 to the ER is compelling. However, the evidence for plasma membrane localization is not as clear and should be supported by additional evidence (including higher resolution images) and/or more careful discussion. In particular, can the authors discount the possibility that TgTRPPL-2 also localizes to the IMC, which has the potential to be a calcium store.

We now include additional IFA experiments of colocalization with the SAG surface marker using super resolution microscopy and Gap45, which is anchored to the Inner Membrane complex. We present the data in Figure 1—figure supplement 1 and panel D of Figure 1. We have modified the text to include the information in the Results section, lines 131-137 and 144-149. According to this result TgTRPPL-2 colocalizes better with the PM marker SAG1, which is supported with the images at ~140 nm resolution as shown in Figure 1—figure supplement 1. The expression level of TgTRPP2 is low but its localization to the ER is very clear. The peripheral localization appears as vesicles in contact with the plasma membrane.

2. The authors need to further clarify their gene/protein model and better justify their proposal that TgTRPPL is cleaved into two proteins/protein isoforms in vivo. Specifically, do the authors have any evidence of different sized proteins in parasite lines expressing epitope tagged proteins or from using antibodies to the native protein(s)?

We now include a western blot (Figure 2—figure supplement 1B) using 4 different cell lines (1. TatiDKu80, 2. TgTRPPL2-smHA, 3. RH and 4. DTgTRRPL2) with the native anti-TgTRPPL2 antibody. In all the cell lines there is a band at ~115-120 kDa, which represents the endogenous cleaved TgTRPPL2. In TgTRPPL2-smHA tachyzoites there is an additional band of ~150 kDa due to the smHA tag which adds approximately 39 kDa to the protein. The sum of these two bands (120 + 150kDa) represents the size predicted for TgTRPPL2 tagged with the smHA tag in ToxoDB. This is discussed in lines 165-173.

3. The authors should clarify the reverse genetic strategy and the experimental conditions used to phenotype the parasites. In particular, while Figure 2A and the text suggest a disruption of trppl2, the method indicates a full deletion. A clear figure depicting the strategy and showing genotyping should be included.

We have included an electrophoresis gel showing genotyping of the insertion (Figure 2—figure supplement 1A). Although the method is designed for deletion, we used the RH strain, which uses Non-homologous end joining repair and homologous recombination is not favored. In this case CRISPR KOs resulted in the insertion of the drug cassette disrupting the transcription of TgTRPPL2. We have validated that the insertion did disrupt the transcription and translation of the TgTRPPL-2 gene by generating an antibody that confirms the absence of TgTRPPL2 in the mutant by both IFA (Figure 2—figure supplement 1 C and D) and western blots (Figure 2—figure supplement 1B), in addition to quantification of RNA transcripts by qPCR (Figure 2B).

4. The authors propose that nifedipine increases basal cytosolic Ca2+ selectively in the in ΔTgTRPPL-2 mutant (Figure 6B) by increasing leakage from intracellular Ca2+ stores as a means to compensate for the absence of plasma membrane Ca2+ influx. However, it is unclear how the absence of plasma membrane Ca2+ entry could couple to enhanced leak from intracellular stores. Moreover, there is no mechanistic explanation for why sensitivity to nifedipine is lost in ΔTgTRPPL-2 and then restored in the complemented mutant (Figure 6D). The authors should further qualify this hypothesis or remove it.

We have consistently found that incubation with nifedipine increases cytosolic calcium in the mutant cell line and unfortunately, we don’t completely understand this phenomenon. We are not sure if this is related to the activity of TgTRPPL-2 at the PM or the ER. It is possible that nifedipine has a secondary effect on a Ca2+ pump that pumps Ca2+ from the cytosol. It could be that the pump interacts with TgTRPPL2 and because of the missing protein the pump is more sensitive to inhibition. This of course is highly speculative, and it would require further investigation. For now, we deleted the figure and redefined Calcium influx as the DCa2+ following the addition of extracellular Ca2+ and show the quantification (Figure 6D). We do not believe that the ΔTgTRPPL-2 mutant lost sensitivity to nifedipine. We think that they are more sensitive (see quantification in 6D, under D). We think that it is hard to separate the activity of TgTRPPL-2 from that of the other channels at the membrane because of the regulatory function of Ca2+ itself on Ca2+ transport. We have re-arranged the figure and explained the results in the text, lines 342-347.

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Figure 1—source data 1. Mass spectrometry results.
    Figure 1—figure supplement 1—source data 1. Summary statistics of Pearson's coefficient analysis.
    Figure 2—source data 1. Statistical analysis of data.
    Figure 3—source data 1. Quantification and statistics of calcium measurements.
    Figure 3—figure supplement 1—source data 1. Quantification and statistics of calcium measurements.
    Figure 4—source data 1. Open probability measurements and statistics.
    Figure 5—source data 1. Channel amplitude measurements, open probability, and statistics.
    Figure 5—figure supplement 1—source data 1. Calcium fluorescence measurements and statistics.
    Figure 6—source data 1. Quantification and statistics of calcium measurements.
    Figure 7—source data 1. Inhibition measurements.
    Source data 1. Original blots.
    Supplementary file 1. Top 10 hits resulting from the analysis of the TgGT1_310560 gene with the HHPRED server.
    elife-63417-supp1.docx (14.8KB, docx)
    Supplementary file 2. Mass spectrometry results of the sliced band after immunoprecipitation of TgTRPPL-2.
    elife-63417-supp2.docx (14.4KB, docx)
    Supplementary file 3. Primers used in this work.
    elife-63417-supp3.docx (14.6KB, docx)
    Supplementary file 4. Composition of the solutions used for the electrophysiological analysis.
    elife-63417-supp4.docx (13.9KB, docx)
    Transparent reporting form

    Data Availability Statement

    All data generated or analysed during this study are included in the manuscript and supporting files.


    Articles from eLife are provided here courtesy of eLife Sciences Publications, Ltd

    RESOURCES